ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000804.1|Acarviostatin_1 # 1 # 4860 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.683	BGC0000804.1|Acarviostatin_1 	1	4860	-	Loose	600	28.8758	clbB	31.34	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGAACCGCAGACATGGCGCGCACGGCGCCTCACGGAAGGCGGCCGCCGCAGCGGTCGCGGCGGCGCTGCTCGGCGCAGCGCTGCACACTGCCACGCCGGCTTCGGCGGCCCCGACACCGCCCAAGCCGCCCTCCGACGCGAAACTGGCCGCGGAGCCCGCACGCCATGATGTGACCCGCGAACAGTTCTACTTCGTCCTGCCCGACCGGTTCGCGAACGGGGACCGGTCCAACGACAGGGGAGGTCTCACCGGCAGCCGCTCGGTGACCGGATTCGACCCCACGGACAAGGGCTTCTACCAGGGCGGCGACCTCAAGGGCCTGACCCGGAAGCTCGACTACATCAAGGGCCTGGGCACCACCGCGATATGGATGGCGCCGATCTTCAAGAACAAACCGGTCCAGGGCAACGGCGAGAGCGCCGGATATCACGGCTACTGGATCACCGACTTCACCCGGGTCGACCCGCACTTCGGCACCAACCAGGACCTGAAGAACCTCGTCTCCAAGGCCCATGCCAAGGGTATGAAGGTCTACTTCGACGTCATCACCAACCACACCGCCGACGTCCTCACCAACACCGAGAAGAAGTACGGCTACCGGAGCAAGGGCGCCTACCCCTACCTCGACACCGAGGGCCGTCCGTTCGACGACACCGAGGAGACCGACCGCAAGGTCGACGAGGACTCGTTCCCCTACACGCCCCAGATCCCGGCTGCGGAGAAGACGGCCAAAGTCCCGGCGTGGCTGAACGACCCGACGATGTACCACAACCGCGGCGACTCGACCTTCGTCGGCGAGAGCGGCCTCTACGGCGACCACACCGGCCTGGACGATCTGTGGACCGAGCGGCCCGAGGTCGTCGAGGGCATGGAGAAGATCTACGAGAGGTGGGTCAAGGACTTCGACATCGACGGCTTCCGCGTGGACACCGTCCGCAACGTCGACATGAAGTTCTGGACGCAGTGGGCCACGGCCCTCGACGCCTACGCCGCCAAGCGGGGCCGGGACGACTTCTTCATCTTCGGTGAGACGCTCTCCGCCGACCCGTCCGTCATCGCCCCGTACGTGACCGAGGGCCGCCTCGACGCGACGCTCGACTTCCCGCTCCAGAACGCCATCCGCGGCTACGCCTCGCAGGGCAAGCCGGCCTCCGGCCTGTCGGACGTCTTCGCACAGGACTACCGGTACACCACGGACAAGGCCAACGCATACAACGAGGTCACGTTTCTCGGCAATCACGACATGGGCCGCATCGGCTCCTTCCTGAAGTCCGATCATCCGGGGGCCGGGGACGCGGAACTGTTGCGGCGAGACCGGCTGGCGCACGAGTTGATGTTCCTGTCGCGGGGCAACCCGGTGATCTACTCCGGCGACGAGCAGGGCTTCACCGGCGCCGGCGGGGACAAGGACGCCCGCCAGACGATGTTCGCGTCGAAGGTGGCGGACTACCTGGACGACGATGAGATCGGTACCAAGCGCACCCACGCGAGTGACGCGTATGACGTGCGGCATCCGCTGTACCGGTCGATCGCGGCGTTGTCGAAGCTGCGCAAGGCGAATCCGGCGTTGGCGGACGGGGTGCAGAAGGAGCTGTACGCGAAGGATTCCGTGTACGCGTTCTCGCGTACGGGGGGTGGCCGGGAGTATGTCGTCGCGGTCAACAACGCGAGTGCGGCGAAGACGGTCGAGCTGCCGGTGGAGAGTCGTGGGTCGGGCAAGTTCCGGTTCCTGTACGGCGGTTCGGGCAAGGTGCGGGCGAAGGATGGACGCATCGAGGTGACGGTGCCGGCTTTGTCGTCGGTGGTGCTGCGTGCGCAGAACAAGCTGAAGCGGCCGTCGGTGCGGCCGTCGGTGTCGCTGCAGGCGCCGGAGGCGGGTGCCACGGGCACGGTGACGATCTCGGCGGATCCGGGGCGGACGGCGGGTGCGCGGGTCGTCCTGGCCGCCCAGGTGGGCAACGGCAGATGGCAGACTCTCGGTTCCGCCGACCACGCTCCGTACAAGTTCACGCAGAAGATCCCCGACTCGGTGGCAGCCGGGACGTCTCTGCGCTACAAGGCCGTGGTGGTCGACCGTGCCGGCCGCACCGCGAGCACACTCGCCGACACCGTGACGGGGCAGGCACCGACGCCGAAGAAGCCGAGCGCCGTGGACCGCGCACACGCAGTCGTGCACTACAAGCGGGCGAACGGCGACTACGACAACGTCCTGCTCAAGTCCGGGGACACGGAAGCACGCTTCGTCGGCCGGGACGCCTACGGTGCCTTCGCCTGGGTGAGGGTTCCGGAGGGATCGGACTCGGTGACGTACACGATCGAGGACTCCGGCACGGCGGAGGGCGGCGAGCGCACCATCGACCTGGCGCAGACCGGTGAGGTCTGGGTCGAGCAGGGCAAGGAGGGTCAGGCGACCACCAAGCCGGACGGGGTGTACCCGTCCCCGGACAAGACGAAGGCGGTCATCCACGTCCACCGCTCCGACGGTGACTACGACGGATGGGGCCTGCACACCTGGACCGGCTCCGCCAAGGAGACGGACTGGACGAAGCCACTGCAGCCCGTCGGCAAGGATGCATACGGGGTCACCTTCGAGGTGCCGCTGTCCGACGGCGCGACCTCACTGAGCTACATCCTGCACAAGGGCGACGAGAAGGACATCCCCAGCGACCGGTCCCTGGACCTGGCCGTGTACGGCAACGAAGTCTGGCTGAACGCGGGGGAGAGCGGCTACTTGCTGCCCTCGGTCGGTTCGGCCCCGGACCTCGACATCACCAAGGCCCAGGCGCAGTGGATCGACACCGACACCGTTGCCCTGCCGCCCTCCATGAACGTCAAGGCCGCCGCGTCGACCCAGTTGGTGTACTCCCGCGACGGTGGCATCACCGTCGACGACGGCGCGCTCAGCAGCGAGGGGCGCTGGCTGCGGCTGCTGCCAGCGCAGCTCACCGAGTCCCAGAAAGCCGCGTATCCCCACCTGAAGGCGTACACGGCGTACACGGTCGACCCACGTGACCGGGACCGAGTGCGTGACGCCCTCTTCGGGCAGCTCATCCTGACCCAACGCCTCGCGAACGGTGCTCTGGCCACCGCGACCGGCGTCCAGATCCAGGGTGTCCTCGACGACGTGTACGCGGGGAAGGCGAAACGGACGGTGTTCGGGCCGGTGTTCAAGGGCCGCACCGCGTCCTTGACGGTCTGGGCACCGACGGCTCACAAGGTGTCCCTCGAACTCGACGGCAGAACCATCCCCATGCGCCGTGACGACGCGAGCGGCGCTTGGTCGGTGACCGGCCCCGCAGCCGCCTGGCGAGGCAAGGAGTACCGGTACGCGGTGACTGTGTGGGCACCCAGTGTCCAGAAGGTCGTCACCAACAAGGTCACCGACCCGTACTCCCTCGCCCTGACCACCGACTCCGAGCGCAGCCTCGTCGTCGACCTGGACGACCGCTCCCTCGCCCCGCGCGGCTGGGAGCACTACCGCAAGCCCGAGGCGGTGCCGCTCAGGGATGCCCAGATCCAGGAGCTGCACATCCGCGACTTCTCCGTCGCCGACCCGACGGCGGACGCGGACCACCGGGGCACCTACCTCGCCTTCACCGACGAGAAGAGCGACGGCTCGAAGCACCTGCGCGAGCTGGCCGGGGCTGGCACGTCCTACGTGCACCTGCTGCCCGCCTTCGACATCGCCACCATCCCCGAGAAGAAGTCCGAGCAGACGGTGCCCGGCTGCGACCTCGCCGCCTACCCGGCCGACTCCGAGAAGCAGCAGGAGTGCGTGACGAAGGCCGCCGCCAAGGACGCCTTCAACTGGGGCTACGACCCGTACCACTACACGGTCCCCGAGGGCTCCTACGCCACCGACCCCGACGGCACCGGGCGCACCGTCGAGTTCCGCAAGATGGTCAAGGCCCTCAACGACGACGGGCTGCGCGTCGTCATGGACGTCGTCTACAACCACACGGCCGCGAGCGGGACAGGCGAAGACCAGCGTCCTCGACCGGATCGTGCCCGGCTACTACCAGCGGCTGCTCGCCGACGGCTCGGTCGCCAACAGCACCTGCTGCTCCGACACGGCCACCGAGAACGCCATGATGGGCAAGCTCGTCGTCGACTCGGTCGTCACCTGGGCCAAGGAGTACAAGGTCGACGGCTTCCGCTTCGACCTCATGGGCCACCACCCCAAGGCCAACATCCTCGCGGTCCGCAAGGCGCTGGACGAGCTGACGCTCAAGAAGGACGGCGTCGACGGCAAGAAGATCATCCTGTACGGCGAGGGCTGGAACTTCGGCGAGGTCGCCGACGACGCCCGCTTCGTCCAGGCCACCCAGAAGAACATGGCCGGCACCGGCATCGCCACCTTCTCCGACCGGGCCCGCGACGCCGTGCGCGGCGGCGGCCCCTTCGACGAGGACCCCGGCGTCCAGGGCTTCGCCTCCGGCCTCTACACCGACCCCAACTCCTCGAAGGCCAACGGCACCGAGGCCGAGCAGAAGGCCCGCCTCCTGCACTACCAGGACCTGATCAAGGTCGGCCTGACCGGCAACCTCGCCGACTACGCCTTCACCGACACCGACGGCAAGGAGGTCAAGGGCTCCGAGGTCGACTACAACGGCGCCCCCGCCGGATACGCGGCGGCACCCGGCGACGCCCTCGCCTACGCCGACGCGCACGACAACGAGTCCCTGTTCGACGCGCTCGCCTTCAAGCTGCCCAAGGACACGTCCGCCGACGACCGGGCCCGCATGCAGGTCCTCGCCATGGCGACCGCCGCCCTCTCGCAGGGCCCGGCGCTGTCCCAGGCGGGCACCGACCTGCTGCGCTCCAAGTCGCTGGACCGCAACTCCTTCGACAGCGGTGA	MNRRHGAHGASRKAAAAAVAAALLGAALHTATPASAAPTPPKPPSDAKLAAEPARHDVTREQFYFVLPDRFANGDRSNDRGGLTGSRSVTGFDPTDKGFYQGGDLKGLTRKLDYIKGLGTTAIWMAPIFKNKPVQGNGESAGYHGYWITDFTRVDPHFGTNQDLKNLVSKAHAKGMKVYFDVITNHTADVLTNTEKKYGYRSKGAYPYLDTEGRPFDDTEETDRKVDEDSFPYTPQIPAAEKTAKVPAWLNDPTMYHNRGDSTFVGESGLYGDHTGLDDLWTERPEVVEGMEKIYERWVKDFDIDGFRVDTVRNVDMKFWTQWATALDAYAAKRGRDDFFIFGETLSADPSVIAPYVTEGRLDATLDFPLQNAIRGYASQGKPASGLSDVFAQDYRYTTDKANAYNEVTFLGNHDMGRIGSFLKSDHPGAGDAELLRRDRLAHELMFLSRGNPVIYSGDEQGFTGAGGDKDARQTMFASKVADYLDDDEIGTKRTHASDAYDVRHPLYRSIAALSKLRKANPALADGVQKELYAKDSVYAFSRTGGGREYVVAVNNASAAKTVELPVESRGSGKFRFLYGGSGKVRAKDGRIEVTVPALSSVVLRAQNKLKRPSVRPSVSLQAPEAGATGTVTISADPGRTAGARVVLAAQVGNGRWQTLGSADHAPYKFTQKIPDSVAAGTSLRYKAVVVDRAGRTASTLADTVTGQAPTPKKPSAVDRAHAVVHYKRANGDYDNVLLKSGDTEARFVGRDAYGAFAWVRVPEGSDSVTYTIEDSGTAEGGERTIDLAQTGEVWVEQGKEGQATTKPDGVYPSPDKTKAVIHVHRSDGDYDGWGLHTWTGSAKETDWTKPLQPVGKDAYGVTFEVPLSDGATSLSYILHKGDEKDIPSDRSLDLAVYGNEVWLNAGESGYLLPSVGSAPDLDITKAQAQWIDTDTVALPPSMNVKAAASTQLVYSRDGGITVDDGALSSEGRWLRLLPAQLTESQKAAYPHLKAYTAYTVDPRDRDRVRDALFGQLILTQRLANGALATATGVQIQGVLDDVYAGKAKRTVFGPVFKGRTASLTVWAPTAHKVSLELDGRTIPMRRDDASGAWSVTGPAAAWRGKEYRYAVTVWAPSVQKVVTNKVTDPYSLALTTDSERSLVVDLDDRSLAPRGWEHYRKPEAVPLRDAQIQELHIRDFSVADPTADADHRGTYLAFTDEKSDGSKHLRELAGAGTSYVHLLPAFDIATIPEKKSEQTVPGCDLAAYPADSEKQQECVTKAAAKDAFNWGYDPYHYTVPEGSYATDPDGTGRTVEFRKMVKALNDDGLRVVMDVVYNHTAASGTGEDQRPRPDRARLLPAAARRRLGRQQHLLLRHGHRERHDGQARRRLGRHLGQGVQGRRLPLRPHGPPPQGQHPRGPQGAGRADAQEGRRRRQEDHPVRRGLELRRGRRRRPLRPGHPEEHGRHRHRHLLRPGPRRRARRRPLRRGPRRPGLRLRPLHRPQLLEGQRHRGRAEGPPPALPGPDQGRPDRQPRRLRLHRHRRQGGQGLRGRLQRRPRRIRGGTRRRPRLRRRARQRVPVRRARLQAAQGHVRRRPGPHAGPRHGDRRPLAGPGAVPGGHRPAALQVAGPQLLRQR	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	472.01	gnl|BL_ORD_ID|112|hsp_num:0	127		
BGC0000804.1|Acarviostatin_2 # 4857 # 7985 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.674	BGC0000804.1|Acarviostatin_2 	4857	7985	-	Loose	600	32.3426	clbB	32.84	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGACCGGCTCTCTGCGAAGATCCGTTCTCACCACGGCGCTGGTGACCGTTCTGGCCACGGCCCTGCCCGCACCCGCGCACGCGGCGTCCGCACCCACGGCACCCGCGCCCCCACCCGACGCATGGCTGGCAGCGCAGCCCGCACGCCCTTCAGTGAGCAGGGAACAGTTCTACCTCCTCATGCCGGACCGCTTCGCGAACGCAGACCCGTCCAACGACCGAGGAGGCCTCAGCGGCGACCGCTACAGCACGGGCTACGACCCGACGGACAAGAATTTCTACCAGGGCGGCGACCTCAAGGGCATCACGCGCAGGCTCGACTACATCAAGGGACTGGGCACCACCGCGATCTGGCTCACGCCCGTGTTCCGCAACAAGACGGTGCTGGAACGGGGCGGCAAGAAGACCGCCTCCTATCATGGCTACGCCGTCACCGACTTCACCAGCGTCGACCCGCACTTCGGTTCGGAACGCGATCTCACCGACCTCATCTCCAAGGCCCATGCCAAGGGTATGAAGGTCTACTTCGACGTCATCACCAATCACACCGCCGACACCGTCGACTACGCGGAGAAGAAGTACGGCTACCGGAGCAAGGGCGCCTACCCGTACCTGGACGCGTCGGGCCAGCCCTTCGACGACGCCGAGGCCATGTCGAAGGTCGACCGGGACTCCTTCCCGTACACGCCGGAGAACACCGGCGAGATGGTCCCCGAGTGGCTGAACGACCCGACGATGTACCACAACCGCGGCGACTCGACCTTCGCCGGCGAGAGCGCGCTGTACGGCGACTTCTACGGCCTGGACGATCTGTGGACCGAGCGGCCCGAGGTCGTCCAGGGCATGGAGAAGATCTACGAGAAGTGGGTCGACGACTTCGACGTCGACGGTTTCCGCGTGGACACCGCCAAGAACGTCAACATGGAATTCTGGACGCAGTGGGCCACGGCACTCGACGCCTACGCCGCGAAGAAGGGCCGTGAGGACTTCTTCTTGTTCGCCGAGGCGTTCTCCGCCGACCCGGCCATCACCGCTCCCTACCTCACCGAGGGCCGCCTCGACGGAACTCTCGACTTCCCGCTCCAGTCCGCCATCCGCAACTATGCCTCACGAGGCGGCCCCGCCGGTGACCTGGCCACCGTCTTCGCGCAGGACTACCGGTACACCACGGACAAGACGAACGCGTACAGCCAGGTCACGTTTCTCGGCAGCCATGACATGGGCCGTATCGGCTTCTTCCTGAAGTCCGATCATCCGGGGGCCGGGGACGCGGAACTGTTGCGGCGGGACCGGCTGGCGCACGAGTTGATGTTCCTGTCGCGGGGCAACCCGGTGATCTACTCCGGTGACGAGCAGGGCTTCACCGGCGCCGGGGACGACGTCTACGGTCGTCAGTCGATGTTCGCGTCGAAGGTGGCGGACTACCTGGACGACGACGAGATCGGTACGGAGCGTACGCATGCGAGTGACGCGTATGACGTGCGGCATCCGCTGTACCGGTCGATCGCGGCGTTGTCGAAGCTGCGCAAGGCGAATCCGGCGTTGGCGGACGGGGTGCAGAAGGAGCTGTACGCGGGGGATTCCGTGTACGCGTTCTCGCGTACGGGGGGTGGCCGGGAGTATGTCGTCGCGGTCAACAACGCGAGTGCGGCGAAGACGGTCGAGCTGCCGGTGGAGAGTGCCGGATCGGGCAAGTTCCGTGTCTTGTACGGCGGTTCGGGCAGGGTGCGGGCGAAGGACGGGCGCATCGAGGTGACGGTGCCGGCTTTGTCGTCGGTGGTGCTGCGTGCGCAGAACAAGCTGAAGCGGCCGTCGGTGCGGCCGTCGGTGTCGCTGCAGGCGCCGGAGGCGGGTGCCACGGGCACGGTGACGATCTCGGCGGATCCGGGGCGGACGGCGGGTGCGCGGGTCGTCCTGGCCGCCCAGGTGGGCAACGGCAGATGGCAGACTCTCGGTTCCGCCGACCACGCTCCGTACAAGTTCACGCAGAAGATCCCCGACTCGGTGGCAGCCGGGACGCCTCTGCGCTACAAGGCCGTGGTGGTCGACCGTGCCGGCCGCACCGCGAGCACACTCGCCGACACCGTGGCGGGGCAGGCACCGACGCCGAAGAAGCCGACGGCCGAACGCCGCCACGTCGTCGTGCACTACCACCGCGCCGACGGCGACTACACCGGCCTGACGCTGCACACCGCGAACGGGACCACCGCCGACTTCTCGGGACGGGACGCCTACGGAGCGTTCGCATGGCTCAGCCCCGCGGAGGGGACCGGGAAGATCCGATTCACGGTCGAGCGTGACGGTAAACCCGAAGGCGCCGAGCGTGTCGTGGACGTCGCCGCGGCCGGTGAGGTATGGACGAAGGAGAACGCGGACCTCGTGGACGCCGTCCGTCCCGCGGACGCCTATCCACCTCAGGACACGACGAAGGCCGTCCTCCACTACCACCGTCCGGACGGCGACTACGCCGGCTGGGGCTTGCACACCTGGACCGGAGCCGCGAACCCGTCCGAGTGGAACGAACCGATCCAGCCGGTACGCCGCGACGCCTACGGTCTCGTATTCGAAGTGCCTCTCAAAGCGGGTGCGCCTTCCCTGAGCTACGTCTTCCACAAGAAGGAAGAAAAGGACGTCCCGGCCGACGAGGCACTTGTCTTCTCCTTGTACGGCCACGAGGTGTGGCGCGTCGCGGGCGAGGCGCCCTATCTGACGCCGTCCCTCGGCGGTGCCTTCCCGATGGATCTCGATCCCGCGGCCTCCGCGGCCACTTGGATCGACGAGAACACCGTCGTGTGGCACGGCACCGGCACGGGCGTCGCCGCCCAGCAACTCGTCTACGCCGCGGACGGGGGTCTGACTCTGCGGGACGGCGTCCTGTCCGACGAAGGGCAGTGGCTACGTCTCGTCCCCACCGAGCTGAGCGCGGCTCAGCAGGCGGCGCACCCCGAACTCGCCGACACCACGGCGTTCTCCATCGACCCGCGCGACCGCGACCGCATCCCCGAAGCACGCCGGGCCAAGCAGCTCATCGCCACCCAACGTTCCGACAACGGAGCTCTGTTGGGTGCAACGAGCGTGACAGCACTGTTCTCCACGCCCCAGCATGTCCAGAAGGGTTCGACCAGGTGA	MTGSLRRSVLTTALVTVLATALPAPAHAASAPTAPAPPPDAWLAAQPARPSVSREQFYLLMPDRFANADPSNDRGGLSGDRYSTGYDPTDKNFYQGGDLKGITRRLDYIKGLGTTAIWLTPVFRNKTVLERGGKKTASYHGYAVTDFTSVDPHFGSERDLTDLISKAHAKGMKVYFDVITNHTADTVDYAEKKYGYRSKGAYPYLDASGQPFDDAEAMSKVDRDSFPYTPENTGEMVPEWLNDPTMYHNRGDSTFAGESALYGDFYGLDDLWTERPEVVQGMEKIYEKWVDDFDVDGFRVDTAKNVNMEFWTQWATALDAYAAKKGREDFFLFAEAFSADPAITAPYLTEGRLDGTLDFPLQSAIRNYASRGGPAGDLATVFAQDYRYTTDKTNAYSQVTFLGSHDMGRIGFFLKSDHPGAGDAELLRRDRLAHELMFLSRGNPVIYSGDEQGFTGAGDDVYGRQSMFASKVADYLDDDEIGTERTHASDAYDVRHPLYRSIAALSKLRKANPALADGVQKELYAGDSVYAFSRTGGGREYVVAVNNASAAKTVELPVESAGSGKFRVLYGGSGRVRAKDGRIEVTVPALSSVVLRAQNKLKRPSVRPSVSLQAPEAGATGTVTISADPGRTAGARVVLAAQVGNGRWQTLGSADHAPYKFTQKIPDSVAAGTPLRYKAVVVDRAGRTASTLADTVAGQAPTPKKPTAERRHVVVHYHRADGDYTGLTLHTANGTTADFSGRDAYGAFAWLSPAEGTGKIRFTVERDGKPEGAERVVDVAAAGEVWTKENADLVDAVRPADAYPPQDTTKAVLHYHRPDGDYAGWGLHTWTGAANPSEWNEPIQPVRRDAYGLVFEVPLKAGAPSLSYVFHKKEEKDVPADEALVFSLYGHEVWRVAGEAPYLTPSLGGAFPMDLDPAASAATWIDENTVVWHGTGTGVAAQQLVYAADGGLTLRDGVLSDEGQWLRLVPTELSAAQQAAHPELADTTAFSIDPRDRDRIPEARRAKQLIATQRSDNGALLGATSVTALFSTPQHVQKGSTR	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	303.79	gnl|BL_ORD_ID|112|hsp_num:0	127		
BGC0000804.1|Acarviostatin_3 # 8099 # 9796 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.682	BGC0000804.1|Acarviostatin_3 	8099	9796	-	Loose	400	26.1794	catB9	28.07	3002681	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGCCAGAAAGTCCGTGGCTGCCGCACTCGCCGTCGTGGCGGGAGCCGCTGCCGCCGTCACGGTCCCGGCCCCGGCGCAGGCCGCGCCGGTCGGAGACAAGGACGTCACCGCGGTGATGTTCGAGTGGAACTTCGCATCGGTTGCCAAGGAGTGCACCGACACGCTCGGCCCCGCCGGCTACGGCTACGTCCAGGTCTCACCGCCCAACGAGCGGGTGCAGGGCAGCCAGTGGTGGACCGCCTACCAGCCGGTCAGCTACAAGATCGCCACCCGGCTCGGTGACCGCGCCGCGTTCAAGAGCATGGTCGAGACCTGTCACGCGGCCGGAGTGAAGGTCGTGGCCGACACCGTCATCAACCACATGGCCAACTCCTCCGGCACGGGTACCGGCGGCTCCACGTACAGCAAGTACGACTACCCGGGCACCTACTCCGGCGCGGACATGGACGACTGCCGCACCGACATCACCGATTACCGGGACCGCTGGAACGTCCAGCACTGCGAGATGGGCAGTCTGCCCGACCTCGACACCGGCGAGGAGTACGTCCGGAAGACCATCGCAGGGTACCTGAACGACCTGCTCTCCCTGGGCGTCGACGGATTCCGCGTCGACGCCGCCAAGCACATCGCCGTCGACGATCTCAAGGACATCAAGTCGCGGCTCACCGACCCGAACGCGTACATGAAGCTGGAAACGATCGGAGCCCCGGGGGAGGCCGTGCAGCCCAGTGAGTACCTGGGCGTCGGCGACCCGCAGGAGTTCACGTACGCCTATGATCTCAAGCGGGTCTTCAGCGGCGAGAAGCTCGCGTACCTGAAGAACTTCGGGGAGGACTGGGGGTACCTGCCGAGCGACAAGGCGTCCGTGTTCGTGACCAACCACGACACCGAACGCAACGGCCGGACGCTCACCTACAAGGACGGCGCCACGTACACGCTCGCCCAGGTCTTCTCGCTGGCCTGGCCGTACGGAGCTCCGGACGTGCACTCCGGCTACTCCTTCACCGACACGGCGGCGGGCGGCCCCAACGGCGGCCAGGTGAACGCCTGCTACACCGACGGCTGGAAGTGCCAGCACGCCTGGCGCGAGGTCGCGAGCATGGTCGCCTGGCGCAACACCGCCCACGGCGAGGCCGTGACGGACTGGTGGGACAACGGGAACAACCAGATCGCCTTCGGCCGCGGATCCAAGGCGTACGTCGCCATCAACCACGAGGGCGGATCGCTGACCCGCACGTTCCAGACCTCCCTGCCCGCCGGTGACTACTGCGACGTGCAGAGCGGCAAGGGCGTCACGGTGAACTCCGCCGGCCAGTTCACGGCCACGCTCGGGGCGAACACCGCGCTGGCCCTGCACGTCGGTGCAAAGACCTGTGGTGGCGGCAGCACCGACCCCGAGCCGGCCGCCGGCGCCTCGTTCCGCGTGAACGCCACGACCAGCTGGGGCGAGAACATCTACGTCACCGGCGACAACACCCGGCTCGGCGACTGGAACCCCGACAACGCACTCAAGCTCGACCCGGCCGCCTACCCGGTCTGGAAGCTCGACGTCAGCCTCCCGGCCGGGACCTCCTTCGAGTACAAGTACCTGCGCAAGGACGCGAACGGCAAGGTCACCTGGGAGAGCGGCGCGAACCGCACCGCGACCGTCTCGTCGTCAGGCACCGTCGTGCTCGGCGACACCTGGCGCGACTGA	MARKSVAAALAVVAGAAAAVTVPAPAQAAPVGDKDVTAVMFEWNFASVAKECTDTLGPAGYGYVQVSPPNERVQGSQWWTAYQPVSYKIATRLGDRAAFKSMVETCHAAGVKVVADTVINHMANSSGTGTGGSTYSKYDYPGTYSGADMDDCRTDITDYRDRWNVQHCEMGSLPDLDTGEEYVRKTIAGYLNDLLSLGVDGFRVDAAKHIAVDDLKDIKSRLTDPNAYMKLETIGAPGEAVQPSEYLGVGDPQEFTYAYDLKRVFSGEKLAYLKNFGEDWGYLPSDKASVFVTNHDTERNGRTLTYKDGATYTLAQVFSLAWPYGAPDVHSGYSFTDTAAGGPNGGQVNACYTDGWKCQHAWREVASMVAWRNTAHGEAVTDWWDNGNNQIAFGRGSKAYVAINHEGGSLTRTFQTSLPAGDYCDVQSGKGVTVNSAGQFTATLGANTALALHVGAKTCGGGSTDPEPAAGASFRVNATTSWGENIYVTGDNTRLGDWNPDNALKLDPAAYPVWKLDVSLPAGTSFEYKYLRKDANGKVTWESGANRTATVSSSGTVVLGDTWRD	MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGSFCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTEAMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWPESWLKESMQSLCSSDIEGLYLNWQSKART	270.33	gnl|BL_ORD_ID|93|hsp_num:0	106		
BGC0000804.1|Acarviostatin_4 # 10118 # 11185 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.707	BGC0000804.1|Acarviostatin_4 	10118	11185	-	Loose	1020	31.187	tlrC	41.18	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGACGGCCTTGCGGCCGCTTCGCGCAACCGAGACCGGCACGCTGCGCCTCCACGACATCGCGGCCCAGGCGGCGGTGAGTGAGGCCACCGTCAGCCGGGTGCTCAACGGCAAGCCCGGCGTCGCCTCCGGTACCCGGCAGAAGGTCCTCGCCGCGCTCGACGTGCTCGGCTACGAGCGGCCGACACGGCTGCGCCGGCGCAGCGCCGGACTCATCGGGTTGGTCATCCCCGAGCTGACCAACCCGATCTTCCCCGCGTTCGCCCAGGTCATCGAGCAGGTCCTCGCGGGATACGGGTACACCCCGGTGTTGTGCACCCAGATGCCGGGCGGGGCGACCGAGGACGAACTGGTCGAACAGCTGGAGGAGCGCGGTGTCAACGGCATCGTGTTCCTTTCCGGGCTGCACGCGGATACCACGGCGGACGCGTTGCGCTACGCGCGGCTCGCCGAGCGGAAGGTGCCGTTCGTCCTCATCAACGGGTTCAACGAACACGTCAACGCGCCGTTCGTGTCCCCGGACGACCGCTCGGCGGCGCGAATGGCCGTGCGTCACCTCGTGGATCTCGGACACGAGCGCATCGGCCTGGCCGTCGGGCCGACCCGTTTCGTACCGTCCCGGCGCAAGGCGGAGGGCTTCGTGGCCGCGCTGCACTCCTTCCTCGGTACTCCCGGTGACGAGGCCGGAAGACTGATCCAGCGCACGCTGTTCAGTGTCGAGGGCGGCCATGCGGCCGCCGGCGCGCTGCTCGACCAGGGCTGCACCGGCATCGTCTGCGGCAGCGATCCGATGGCGCTCGGCGTCATCCGGGCGGTGCGCGAGCGAGGCCTCGACGTGCCGCGGGACGTGTCGGTGATCGGGTTCGACGACTCACCGCTGATCCCGTTCACCGATCCACCGCTGACCACGGTGCGCCAGCCCGTACAGGCCATGGCGACCGCGGCGGTGGGAGCGCTCCTGGAAGAGATCGGCGGTACGCCGGTCCAGCGGACGGAGTACGTGTTCCAGCCCGAGCTGGTGGTGCGGGGCTCTACGGCGCAGGTGGCGCGGAGCCAGGCGCACGCCTAG	MTALRPLRATETGTLRLHDIAAQAAVSEATVSRVLNGKPGVASGTRQKVLAALDVLGYERPTRLRRRSAGLIGLVIPELTNPIFPAFAQVIEQVLAGYGYTPVLCTQMPGGATEDELVEQLEERGVNGIVFLSGLHADTTADALRYARLAERKVPFVLINGFNEHVNAPFVSPDDRSAARMAVRHLVDLGHERIGLAVGPTRFVPSRRKAEGFVAALHSFLGTPGDEAGRLIQRTLFSVEGGHAAAGALLDQGCTGIVCGSDPMALGVIRAVRERGLDVPRDVSVIGFDDSPLIPFTDPPLTTVRQPVQAMATAAVGALLEEIGGTPVQRTEYVFQPELVVRGSTAQVARSQAHA	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	64.78	gnl|BL_ORD_ID|1885|hsp_num:0	1997		
BGC0000804.1|Acarviostatin_5 # 11182 # 12843 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.712	BGC0000804.1|Acarviostatin_5 	11182	12843	-	Loose	400	30.8018	IND-6	26.44	3002262	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGAGCCAGTACCCGACCGACATGGCACCTGCCCGCGTCACCTCCACCCGCGAAGCCGCGGACTGGTGGCGAGACGCCGTCATCTACCAGGTCTACCCGCGCAGCTTCGCCGACAGCAACGGAGACGGCACCGGTGATCTCGAAGGCATCAGGCAGCGCCTCCCGTATCTGCGCGATCTTGGCGTGGACGCGGTCTGGCTGAGCCCGTTCTACGCCTCTCCGCAGGCGGACGGCGGCTACGACGTCGCCGACTACCGTGCCGTCGACCCCATGTTCGGCACTCTGCTGGACGCCGACGCGCTGATCCGCGACGCCCACGCCCTGGACCTGCGCATCATCGTCGACCTGGTGCCGAACCACTCCTCGGACCAGCACGAGTGGTTCAGGCGCGCGGTCGCCGAGGGGCCCGGGTCGCCGCTGCGGGAGCGCTACCACTTCCGCCCCGGCAAGGGAGAGAACGGGGAACTGCCCCCCAACGACTGGGAGTCCATCTTCGGTGGCCCCGCCTGGACCCGGCTGCCGGACGGCGAGTGGTACCTGCACCTCTTCGCGCCCGAGCAGCCCGACCTCAACTGGGAACACCCCGCCGTCGCCGACGAGTTCCGCTCGATCCTGCGGTTCTGGCTGGACATGGGCGTCGACGGCTTCCGCATCGATGTCGCCCACGGCATGGTCAAGGCCGAGGGCCTGCCCGACCTCGGCGGAAGCGACCAGCTCAAGCTGCTCGGCACCGACGTCATGCCGTTCTTCGACCAGGACGGTGTCCACGACATCTACCGCGCCTGGCGCCTCATCCTCAACGAGTACGACCGGGACAGGATCTTCGTCGCCGAGGCATGGACCCCGACCGTCGAGCGCACCGCCAACTACGTCCGTCCCGACGAACTGCACCAGGCCTTCAACTTCCAGTACCTGGGCGCACCCTGGGACGCCGCCGAACTCCGCGCGATCATCGACAGCTCCCTCGACGCCATGCGACCCGTCGGCGCCCCGGCGACCTGGGTGCTGTCCAACCACGACGTCACCCGGCACGCCACCCGGTACGCCAACCCGCCCGGCCTCGGCACGCAGATCCGCACTCCCGGTGACCGCGCGCTGGGCCTGCGTCGTGCCCGCGCCGCGACGCTGCTGATGCTCGCGCTGCCCGGCTCCGCCTACATCTACCAGGGCGAGGAACTCGGCCTGCCCGACGTCACCGACCTGCCCGACGAACTGCGCCAGGACCCGTCCTTCTTCCGGGCCCAGGGCCAGGACGGCTTCCGCGACGGCTGCCGGGTGCCGATCCCGTGGACCCGCGAGGGCTCCTCGTACGGCTTCGGCGCCGGCGGCAGCTGGCTGCCGCAGCCGGCGGGCTGGGGCGAGCTGAGCGTCGAGGCGCAGACCGGCGTCGCCGGCTCCACTCTCGAGCTGTACCGCACCGCCCTCGCCGTGCGCCGCGAGCAGCCGGGCCTCGGCGCCGGCACCGACGTGGTCTGGCACGACGACGCCCCGACCGGAACCCTGAGGTTCGACCGGCCCGGCTTCGCGTGCACCGTCAATACGACGGGGAGCGCGGTCCGCATCGCGGCACCCGGCCGCGTACTGCTCGCATCGAGCCCGGTCAGGGCAAGCGGCGACGAGTTCGAACTGCCCGCCGACACGGCCGTCTGGTGGGAGGTATGA	MSQYPTDMAPARVTSTREAADWWRDAVIYQVYPRSFADSNGDGTGDLEGIRQRLPYLRDLGVDAVWLSPFYASPQADGGYDVADYRAVDPMFGTLLDADALIRDAHALDLRIIVDLVPNHSSDQHEWFRRAVAEGPGSPLRERYHFRPGKGENGELPPNDWESIFGGPAWTRLPDGEWYLHLFAPEQPDLNWEHPAVADEFRSILRFWLDMGVDGFRIDVAHGMVKAEGLPDLGGSDQLKLLGTDVMPFFDQDGVHDIYRAWRLILNEYDRDRIFVAEAWTPTVERTANYVRPDELHQAFNFQYLGAPWDAAELRAIIDSSLDAMRPVGAPATWVLSNHDVTRHATRYANPPGLGTQIRTPGDRALGLRRARAATLLMLALPGSAYIYQGEELGLPDVTDLPDELRQDPSFFRAQGQDGFRDGCRVPIPWTREGSSYGFGAGGSWLPQPAGWGELSVEAQTGVAGSTLELYRTALAVRREQPGLGAGTDVVWHDDAPTGTLRFDRPGFACTVNTTGSAVRIAAPGRVLLASSPVRASGDEFELPADTAVWWEV	MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKTGVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLVKSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK	231.38	gnl|BL_ORD_ID|552|hsp_num:0	590		
BGC0000804.1|Acarviostatin_6 # 12899 # 13804 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.655	BGC0000804.1|Acarviostatin_6 	12899	13804	-	Loose	700	24.6386	ugd	31.03	3003577	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGCACCCAGACCCTTTCCACCTCACCGGCCCTGGACCCGGTCGAGACGTCCGTGCCGCGCAACGCTCCGCGCCGTGGCCGGCGCAGCCGCGGGGTTTCGGTGGCCACGCACGCCGTGCTGGTCGTCGCGAGCCTCGTCGCGCTGTTCCCGATCGGCTGGCTGGTGTTCCTCTCGCTCGGCCCGGGCAAGGACGACTACCTCCACCCCTCCCGCATCCTCGACACCGCGACCCTGAGCAACTACTCGTTCGTGCTCGAGCACACCAACTTCCTCAAGTGGCTGGGCAATACGCTCATCGTGTCCCTCGGCACCACCGTGATCGGGGTACTCGTGGCGGCGACCAGCGGATACGCCGTCTCACGGATGCGTTTCCCGGGCTACAAGAAGTTCATGTGGGTCCTGCTGATCACGCAGATGTTCCCCATCGCGGTCCTGATGGTCCCGATGTACGTGATCCTCTCGGACCTCCGCCTCATCGACACCTACGCGGCGCTCATCCTGGTCTATCTCACGACCGCGGTGCCGTACTGCGCCTGGCTGATGAAGGGCTACTTCGACACGATCCCCGTCGAGATCGACGAGGCCGGCCGGGTCGACGGACTCTCGCCGTTCGGCACGTTCTTCCGTCTGATCCTGCCACTGGCCCGCCCGGGCCTGGCCGTCGCTGGGTTCTACACCATGATCACGGCCTGGAGCGAGGTCGCGTTCGCCACCACGTTCATGCTCGACGACCAGAAGTACACCCTCGCCGTCGGCCTGCAGAGCTTCGTCAGCGAGCACGACGCGCAGCGTCAGTACATGGCCGCGACGGCCGTACTGATCGCCATCCCGATCTCCGCAGTCTTCTACCTCGTTCAGAAGAACCTGGTGACCGGTCTGACAGCCGGTGGCACCAAGGGCTGA	MSTQTLSTSPALDPVETSVPRNAPRRGRRSRGVSVATHAVLVVASLVALFPIGWLVFLSLGPGKDDYLHPSRILDTATLSNYSFVLEHTNFLKWLGNTLIVSLGTTVIGVLVAATSGYAVSRMRFPGYKKFMWVLLITQMFPIAVLMVPMYVILSDLRLIDTYAALILVYLTTAVPYCAWLMKGYFDTIPVEIDEAGRVDGLSPFGTFFRLILPLARPGLAVAGFYTMITAWSEVAFATTFMLDDQKYTLAVGLQSFVSEHDAQRQYMAATAVLIAIPISAVFYLVQKNLVTGLTAGGTKG	MKITISGTGYVGLSNGLLIAQNHEVVALDILPSRVAMLNDRISPIVDKEIQQFLQSDKIHFNATLDKNEAYRDADYVIIATPTDYDPKTNYFNTSSVESVIKDVVEINPYAVMVIKSTVPVGFTAAMHKKYRTENIIFSPEFLREGKALYDNLHPSRIVIGERSERAERFAALLQEGAIKQNIPMLFTDSTEAEAIKLFANTYLAMRVAYFNELDSYAESLGLNSRQIIEGVCLDPRIGNHYNNPSFGYGGYCLPKDTKQLLANYQSVPNNLISAIVDANRTRKDFIADAILSRKPQVVGIYRLIMKSGSDNFRASSIQGIMKRIKAKGVEVIIYEPVMKEDSFFNSRLERDLATFKQQADVIISNRMAEELKDVADKVYTRDLFGSD	77.58	gnl|BL_ORD_ID|916|hsp_num:0	842		
BGC0000804.1|Acarviostatin_7 # 13827 # 14834 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.663	BGC0000804.1|Acarviostatin_7 	13827	14834	-	Loose	550	25.0238	vanHA	53.85	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGACTGTCGCCGTGGAGCGCCCGGCCGCACCCAGTGGTGACGACCGCGGCCGGCGTCCGGGCCTCATCACCCGTCTCAAGAGCGGCTACCAGAAGCACTGGTACGCCTACGCGATGATCGCCCCGGTCGTTGTCGTGCTCGCCGTCATCGTGCTGTATCCGCTGGTCCGGGGCTTCTATCTGACGCTGACGGACGCCACGAGCCTCAACTCCGCCCGCACCATCGGCGTCAACCACATCGACGCCACCTACAAGTTCATCGGCCTCGACAACTACGCCGACATCCTGTGGGGACCGACGGCGTACGACCGCTTCTGGTCCCACTTCATCTGGACCATCGTCTGGACGGCCGCCTGCGTCGCGCTGCACTACGGTCTCGGTCTCGGCCTGGCCCTGCTGCTCAACCAGAAGGGGCTGCGCGGCCGCACCGCCTACCGGATGATGCTCATCCTGCCGTGGGCCGTGCCGACGTTCGTCACCGTCTTCGCCTGGCGCTTCATGCTCGCCGATGCCGGCGTCGTCAACACGACGCTCGACGCGCTCGGGATGCCCTCGCCGGCCTGGCTGGAGGATCCGCTCTTCCAGCAGATCGCCGCCATCATGGTCAACACCTGGTGCGGTGTGCCCTTCATGATGGTCTCGCTCCTCGGCGGCCTGCAGTCGATCGACTCGACGCTGTACGAAGCAGCGGAGATGGACGGCGCGAACGCCTGGCAGCAGTTCCGCAACGTGACCCTGCCCGGGCTCAGGTCGGTCAGCTCCACGGTCGTGCTGCTCGGCGTGATCTGGACGTTCAACCAGTTCGCGATCATCTTCCTGCTCTTCGGCAACACCGCGCCGGACGCGCAGATCCTGGTCACCTGGGCCTACTACCTCGGCTTCGGACAGACTCCGCGCGACTACGCCCAGTCCGCGACGTACGGCGTCCTGCTGCTGTCCCTCCTCATCGTGTTCACCTCCGTCTACCGCCGCTGGCTGAACCGCAACGACGTGCAAGCCGCCATCTGA	MTVAVERPAAPSGDDRGRRPGLITRLKSGYQKHWYAYAMIAPVVVVLAVIVLYPLVRGFYLTLTDATSLNSARTIGVNHIDATYKFIGLDNYADILWGPTAYDRFWSHFIWTIVWTAACVALHYGLGLGLALLLNQKGLRGRTAYRMMLILPWAVPTFVTVFAWRFMLADAGVVNTTLDALGMPSPAWLEDPLFQQIAAIMVNTWCGVPFMMVSLLGGLQSIDSTLYEAAEMDGANAWQQFRNVTLPGLRSVSSTVVLLGVIWTFNQFAIIFLLFGNTAPDAQILVTWAYYLGFGQTPRDYAQSATYGVLLLSLLIVFTSVYRRWLNRNDVQAAI	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	104.04	gnl|BL_ORD_ID|164|hsp_num:0	178		
BGC0000804.1|Acarviostatin_8 # 14948 # 16222 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.667	BGC0000804.1|Acarviostatin_8 	14948	16222	-	Loose	500	26.9498	ADC-58	33.33	3004618	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase without carbapenemase activity	ATGCGGCGTGGCATAGTGACCACCGCGGTGGTGGCGTCCCTCGCACTCGCGGCGACGGCCTGCGGCGGAAGCGATGACGGGGGCAAGGCCTCCGGCCCCGTGACCATCACATGGTGGGACACGTCGAACGCCACCAACGAGGCGCCCACGTACAAGGCCCTGATCAAGGACTTCGAGAAGGCCAACCCGGACGTCAAGGTCAAATACGTCAACGTCCCCTTCGACCAGGCCCAGAACAAGTTCGACACGGCGGCCGGCGCCAGCGGCGCACCCGACGTGATTCGTGCCGAGGTCGGCTGGACCCCGGCCTTCGCGAAGAAGAGCTACCTGCTGCCGCTCGACGGCACCGTGGCGCTCGACGAGCAGGACAAGTTCCAGCCGAACCTGATGAAGCAGGCCCAGTACGAGGGCAAGACGTACGGTGTTCCGCTGCTCACCGACACGCTCGCGCTCGTGTACAACAAGGAGCTCTTCGAGAAGGCGGGCATCAGCGAGGCGCCCAAGACCTGGGACGAGCTGAAGAAGGCCGCCGCCACCATCAAGGACAAGACCGGCGTCGACGGGTTCTTCGGTTCCGAGAAGGGCTACTACCTCGAGCCGTTCCTCCTGGGCGAGGGCACCGACACGGTCGACGCCGAGGCCAAGAAGATCACGGTGAACTCCGCCAAGGGACAGAAGGCGGCCGAGACCTGGCTGAGCCTGTTCAACGGCAAGGGCCTGCACAAGGCGGACGTCACGGCCGACTCGTACGCGCACCGCCAGGACGCGTTCGTCAACGGCAAGGTCGCCATGACCATCGAGGGTCCCTGGGAGATCACGAACTTCTACAAGGGCACCGCGTTCAAGGACAAGAACAACCTCGGTGTCGCCACCGTCCCGGCCGGTTCCACCGGCAAGGCGGCCGCTCCGACGGGCGGCCACAACCTGTCCGTCTACGCCGGATCCGACAAGGCCCACCAGGACGCGGCCCTGCAGTTCGTCAAGTGGATGACCTCCGCGAAGGCGCAGGAGCAGATCGCCCTGAAGAACTCGACGCTGCCCACGCGCTCGGACGCGTACACCGAGAAGGTGACCGCCGACCCCGGCCTCGCCGGATTCCAGAAGGTGCTCTCCGCCGCCCAGCCGCGGCCCGAGCTGCCCGAGTACAGCTCGCTGTGGGGGCCGCTCGACCAGGAGCTGCCCAAGGCGGCCAGTGGCAAGGAGAGCCTCGACGCAGTCCTGTCCTCCGTCGAGGTCCAGTACGGCAAGCTCCTGCCCGACGGCTTCAGCAAGTGA	MRRGIVTTAVVASLALAATACGGSDDGGKASGPVTITWWDTSNATNEAPTYKALIKDFEKANPDVKVKYVNVPFDQAQNKFDTAAGASGAPDVIRAEVGWTPAFAKKSYLLPLDGTVALDEQDKFQPNLMKQAQYEGKTYGVPLLTDTLALVYNKELFEKAGISEAPKTWDELKKAAATIKDKTGVDGFFGSEKGYYLEPFLLGEGTDTVDAEAKKITVNSAKGQKAAETWLSLFNGKGLHKADVTADSYAHRQDAFVNGKVAMTIEGPWEITNFYKGTAFKDKNNLGVATVPAGSTGKAAAPTGGHNLSVYAGSDKAHQDAALQFVKWMTSAKAQEQIALKNSTLPTRSDAYTEKVTADPGLAGFQKVLSAAQPRPELPEYSSLWGPLDQELPKAASGKESLDAVLSSVEVQYGKLLPDGFSK	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK	110.70	gnl|BL_ORD_ID|2128|hsp_num:0	3316		
BGC0000804.1|Acarviostatin_9 # 16248 # 16673 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.620	BGC0000804.1|Acarviostatin_9 	16248	16673	+	Loose	550	23.0978	OXA-158	37.93	3001463	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGTGGGCGAGGAACGGTCCCGTCCGTACCTCTGGCCGACTTGCCGACTGAGCCGTCGCGGCCACCGGGCGACGTGAACGTAACAGTGGAGAAAGACTGGCGAAAGACGTTGCGCGAATTTTCTGCAAGAACTGCCCATCGTTACTTCTTCGTATCCCATCGGTTGCCGACGGAATACTTGACGTGGCGCGCATCCTTGAGACGCAGTGGCGCGAATCACCGCAAAATAGATGATGATGGGCCCGGTCCGCCCAACAGCTTCCCTCTTCGTGCCGCACGGGGCTGCAAGGTCTTCCGCAAGGACACCGGCTACACCATCACGGTGGCCGTCCGGTGCTGGTGGGCTTTCCCCCTGGTAACGGGTAGAGTCCCTGTCCATGACCGCGCGGCTCTCCGACATCGCAGCCCAGGCGGGAGTCAGTGA	MSGRGTVPSVPLADLPTEPSRPPGDVNVTVEKDWRKTLREFSARTAHRYFFVSHRLPTEYLTWRASLRRSGANHRKIDDDGPGPPNSFPLRAARGCKVFRKDTGYTITVAVRCWWAFPLVTGRVPVHDRAALRHRSPGGSQ	MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVKGTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRRVKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDSLQISAREQVDFLQRLATGTLPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGWWVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI	49.82	gnl|BL_ORD_ID|2657|hsp_num:0	3422		
BGC0000804.1|Acarviostatin_10 # 16627 # 17655 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000804.1|Acarviostatin_10 	16627	17655	+	Loose	570	25.7942	OXA-151	46.43	3001456	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGCGCGGCTCTCCGACATCGCAGCCCAGGCGGGAGTCAGTGAAGCCACCGTCAGCCGCGTGCTCAACGGCAAGCCAGGAGTGGCCACCGGCACCCGCGAGTCCGTCATGGCGGCACTCGACGTACTCGGGTACGAGCGACCGCCGCGGTTGCGCACCCGAAGCGCCGGCCTGGTGGGCCTGATCACCCCCGAGCTGGACAATCCCATTTTCCCCGCGCTCGCCCAGGTCATCGGCCAGGCGCTCACGCGCCAGGGATACACGCCGGTCCTCGCCACCCAGACTCCGGGCGGCTCGACCGAGGACGAACTCACCGAGATGCTGGTGGAACGCAGCGTTTCCGGCATCATCTATGTCTCAGGGCTGCACGCCGACACCACCGCCGACACCCAGAGGTACGACCAACTCCGCGGTCAGGGCATACCGTTCGTGCTCGTCAACGGGTTCTCGGCGCACATCGAGGCCCCTTTCGTATCCACCGACGACCATGCCGCGACGCGCCTGGCCGTGCAGCATCTCGCCTCGCTCGGCCACACGCGGATCGGCCTCGCCGTCGGCCCGCGCCGGTTCGTCCCGGTGCAACGCAAGATCGCGGGCTTCCTGGCCGGGATGTCCGGGTATCTGGGCCTGAGTGAGGAACAGGGCGAGGAGCTTGTGCAGCACTCCCTCTTCACCATGGAGGGCGGCCAGGCAGCGGGTACCGCGCTCCTTGCGCAAGGTTGCACCGCCATCGTCTGCGCCAGCGACATGATGGCGCTGGGCGCCATCCGAGCCGCCCGCCAAGCCGGCTGCCGGGTCCCCCAGGACGTCTCCGTGGTCGGCTTCGACGATTCTCCGCTGATCGCTTTCACCGACCCGCCCCTCACCACCATCCGTCAGCCGGTGCACGCCATGGGCCAGGCCGCCGTCCGCGCGGTTCTCGAGGAGATCGGCGGAACCCCCGCGCCCCACACCGAGTTCATGTTCATGCCCGAGCTCGTGGTACGCGGCTCGACCACCGCGGCGCCCATCACCCGCCCCCGCTGA	MTARLSDIAAQAGVSEATVSRVLNGKPGVATGTRESVMAALDVLGYERPPRLRTRSAGLVGLITPELDNPIFPALAQVIGQALTRQGYTPVLATQTPGGSTEDELTEMLVERSVSGIIYVSGLHADTTADTQRYDQLRGQGIPFVLVNGFSAHIEAPFVSTDDHAATRLAVQHLASLGHTRIGLAVGPRRFVPVQRKIAGFLAGMSGYLGLSEEQGEELVQHSLFTMEGGQAAGTALLAQGCTAIVCASDMMALGAIRAARQAGCRVPQDVSVVGFDDSPLIAFTDPPLTTIRQPVHAMGQAAVRAVLEEIGGTPAPHTEFMFMPELVVRGSTTAAPITRPR	MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFTAEGVKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKPRRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDIGWWVGWIERDGNIASVAINIDMLSEADAPKRARIVKSVLKDLKLI	120.00	gnl|BL_ORD_ID|2588|hsp_num:0	3415		
BGC0000804.1|Acarviostatin_11 # 17674 # 18651 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000804.1|Acarviostatin_11 	17674	18651	-	Loose	1200	37.7354	arnA	23.14	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCCGACGCATCCTCGTCACCGGCGGAGCCGGCTTCATCGGCTCCGCATACGTTCGTGCCCTGCTGGGGCCGGCCGGGCCACCGGGCATCGAGGTGACCGTGCTCGATGCCCTCACGTACGCCGGCAGCCTCACCCGCCTGGAATCCGTCACCGGCGACCCTCGGCTGTCCTTCGTACACGGCGACGTGCTGGATGCCCGTTCGGTGGAGCGGCTCGCCGCTCAACACGAGGACATCGTGCACTTCGCGGCCGAGTCCCACGTCGACCGGTCGATCGCCTCCGGCGCGGCCTTCACCCGCACCAACGTCATGGGCACCCAGACTCTCCTCGACGCCGTGCTCCGACAGGGCACCCGCACCTTCGTCCAGGTCTCCACCGACGAGGTGTACGGCGACCTGCCGGCCGGCGCCGCCACGGAGGACTCCCCGCTGAGCCCCAACTCGCCCTACGCGGCGTCCAAGGCCGCCGCCGACCACGTGGCACTGGCTCATCACCGCACGCACGGCCTGGACGTCCGGGTGACACGCTGTTCGAACAACTTCGGTGCCTACCAGCATCCCGAGAAGCTGATCCCGCGCTTTGTGGCGGCGCTGTTCAGCGGCGGTAAGGTCCCGGTCTACGGGGACGGGCTGCAGGTGCGGGACTGGCTGTCGGTCGACGACCACGTGCGGGGCATCGAACTCGTCCGCACGGCGGGCCGCGCCGGTCGCGTCTACAACATCGGTGGCGGTACCTCACTGACCAACCTCGACCTGACCCACCGGCTGCTCGAACTGTGTGGTGCCGGCCCCGACCGCATTGAGCACGTGGAGGACCGCAAGGGGCACGACCGCCGCTACGCGGTGGACCACACGCGTATCACCCAGGAACTCGGCTACCGACCGTCCGGCGACTTCGAGCGGGCGCTCACGCGGACCGTGGCCTGGTACCGCGAGCACCCGCACTGGTGGCGACCGCTGTACGAGGCAGCCTGA	MTRRILVTGGAGFIGSAYVRALLGPAGPPGIEVTVLDALTYAGSLTRLESVTGDPRLSFVHGDVLDARSVERLAAQHEDIVHFAAESHVDRSIASGAAFTRTNVMGTQTLLDAVLRQGTRTFVQVSTDEVYGDLPAGAATEDSPLSPNSPYAASKAAADHVALAHHRTHGLDVRVTRCSNNFGAYQHPEKLIPRFVAALFSGGKVPVYGDGLQVRDWLSVDDHVRGIELVRTAGRAGRVYNIGGGTSLTNLDLTHRLLELCGAGPDRIEHVEDRKGHDRRYAVDHTRITQELGYRPSGDFERALTRTVAWYREHPHWWRPLYEAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.09	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000804.1|Acarviostatin_12 # 18729 # 19802 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.708	BGC0000804.1|Acarviostatin_12 	18729	19802	-	Loose	400	26.9498	vatE	50.0	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGAAGGCCCTGCTCCTGGCGGGCGGAACGGGTAGCAGACTGCGTCCCTTCACCCACACCGGTGCCAAGCAGCTGATGCCGATAGCCAACCGGCCGGTTCTCTCCTACGCGCTCGACGCGCTGGCGGCCGCCGGAATCGCCGAGACGGGCATCGTCGTCGGCTCCCACGAGAGGGAGATCCGCCGGGTGGTCGGAGACGGCTCGGCCTTCGGCCTGCGGGTCACCTACCTGCGCCAGCACCGCCCCCTGGGCCTCGCCCATGCGGTGCGGATCGCCCGCGACTTCCTGGGTGACGACGACTTCCTCCTCTACCTCGGTGACAACTACCTGCCCGAAGGGATCACCGGTTTCCTGCGGCGAGCCCGGACCGAACGGGCGGCGGCCCGGCTGCTGTTGACGCGGGTCGCCGACCCGACCGCCTTCGGTGTGGCCGAAGTCGAGGGAGGTGACGAAGGCAGGGTGCTGCGGCTGGAGGAGAAGCCCGAACACCCGCGCAGCGATCTGGCCCTCGTGGGCGTCTACGCCTTCACCGCCGCCGTGCACGAGGCGGTCCGGTCCATCTCCCCCTCCGCCCGCGGGGAACTGGAGATCACCCATGCCGTCCAGTGGATGATCGACCAGGGGCTCCCGGTGCGCGCGGAGACCACGGCGGCGCCCTGGCGGGACACCGGCAGCGTCGACGACATGCTGGAGGTCAACCGGCACGTCCTGGACACCGTGACCGGAGGCATCGAGGGCAAGGTCGACGCCGAGAGCACGGTACGCGGACGGGTCCTCGTCGCCGAGGGAGCCGTGGTGCGGGGCTCACGGATCACAGGTCCGGCGATCATCGGCGCCGGAACAGTGGTCACCGACTCCATGATCGGGCCCTATACCGCGGTCGGTGAGGACTGCCGCATCGAGGACAGCGCGATCGCCCACTCGGTGCTGCTGCCCGGGGCACGGATCGCGGGCGCCCCACGCATCGAGGACTCCCTCATAGGCCGCGGCGCGGTCGTCGTGGCGTCCCCGCGGCTGTCGCGCTCGCACAGGCTCGTCATCGGGGACGACAGCAGGGTCCACCTCACTTCGTGA	MKALLLAGGTGSRLRPFTHTGAKQLMPIANRPVLSYALDALAAAGIAETGIVVGSHEREIRRVVGDGSAFGLRVTYLRQHRPLGLAHAVRIARDFLGDDDFLLYLGDNYLPEGITGFLRRARTERAAARLLLTRVADPTAFGVAEVEGGDEGRVLRLEEKPEHPRSDLALVGVYAFTAAVHEAVRSISPSARGELEITHAVQWMIDQGLPVRAETTAAPWRDTGSVDDMLEVNRHVLDTVTGGIEGKVDAESTVRGRVLVAEGAVVRGSRITGPAIIGAGTVVTDSMIGPYTAVGEDCRIEDSAIAHSVLLPGARIAGAPRIEDSLIGRGAVVVASPRLSRSHRLVIGDDSRVHLTS	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	166.82	gnl|BL_ORD_ID|1430|hsp_num:0	1519		
BGC0000804.1|Acarviostatin_13 # 20035 # 21333 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.717	BGC0000804.1|Acarviostatin_13 	20035	21333	+	Loose	750	25.7942	tet(39)	30.88	3000566	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGGCACCAGCACCACCAGCTCGACCAGTTGGAGCGGGAGGAGTTGCGCCTGGCACCCGGAGCCTCCGAGGAGGCGACCGCGGGACGGCGGGTCTTCGCCGAAGGACGCGGCCCCGTACTGACCGACCTGGACGGCAACCAGTACCTCGACTTCGCCGCCGGCACCCTCACTCAGTCCCTCGGGCACACCCATCCCGAGGTGGTCGAGGCGCTCACCGCCCAGGCACACCGGCTGTGGAACGTGCACGACACCGCCACGCCCGACCGGGCGCGACTCCTCGACACCCTGGCCCGGCTGCTTCCCGAACACCTCGACACATACGCGCTGTTCTCCACCGGTGCCGAGGTGGTCGAGGCCGCCCTGCGCGTCGTACAGGCGACCGCGCCGCCGGGACGCAACCGGATCGGCGCGCTGCGGCACGGCTTCCACGGCAAAACGCTGGGGGCACGGATGCTCGTGCACTGGGACATCGGTCACCAGTCGTTCGCGGGCAACAGCGTGCTCGGCTACGCGCCCTACTGCTACCGGTGTCCGCTGGGCCTGGAGTACCCGTCCTGCGGTGTGCGCTGCGCGTCGCTGGTACGCCGGCACATCACCGACAAGCCCAGCACGTCTGCCCTGGTCTTCGAGCCGGTGCTCGGCGCGGCCGGCGTCATCGTGCCGCCGGCCGGCTACTGGGACCAGATCGCCGACGCCTGCCGGGCAAGCGGTGTGCTGCTCGTCGCCGACGAGGTGCTCACCGGCGGCGGTCGCACCGGCGCCTTCCTGGCCAGTGACCGCGTCGGGGTGGAGCCGGATCTGGTGGCCATGTCGAAGGGCATGGCGAACGGCTTCCCCTTCGCCGTGCTCGCGGGCCGCCACGACCTGCTGCACGATCCCGCCGCGGCGACACCGGGTGCGTACGCCTCCACCTATGCGAGCAACCCGCTCGGGATAGCGGCCGCACGCGCGACCCTGGAGGTCATCGAGCGGGACCGCCTGATCGAACAGGTGGACCGTCTCGGCGAGGTGCTCGGTGACCGGCTCCGAGCACTGCACGACCGGTTCGAGAACCTCGGGGAGGTGCGCGGGCTCGGGCTGCTGTGGGGCCTGGAGTTCGTGACCGACCGGGCCAGCCGCACCCCCTCCCCCGCACTCGCCCGCTCCGTGTACACGACCGCGCTGGATCTGGGGCTGCGGGTCGCGCTCGGCGGGCACGTGCTGCGCATCGCACCACCCTTCACGATCGACGAGGCGCTGGTGGACGAGGGTGTCGGACTGCTCGCGAAGGCGATCGAACAGGCGGTGGACGCGTGA	MRHQHHQLDQLEREELRLAPGASEEATAGRRVFAEGRGPVLTDLDGNQYLDFAAGTLTQSLGHTHPEVVEALTAQAHRLWNVHDTATPDRARLLDTLARLLPEHLDTYALFSTGAEVVEAALRVVQATAPPGRNRIGALRHGFHGKTLGARMLVHWDIGHQSFAGNSVLGYAPYCYRCPLGLEYPSCGVRCASLVRRHITDKPSTSALVFEPVLGAAGVIVPPAGYWDQIADACRASGVLLVADEVLTGGGRTGAFLASDRVGVEPDLVAMSKGMANGFPFAVLAGRHDLLHDPAAATPGAYASTYASNPLGIAAARATLEVIERDRLIEQVDRLGEVLGDRLRALHDRFENLGEVRGLGLLWGLEFVTDRASRTPSPALARSVYTTALDLGLRVALGGHVLRIAPPFTIDEALVDEGVGLLAKAIEQAVDA	MKKSLSVILITIFLDAVGIGLIMPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGATADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMSRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQASAPGMVWALAAILYVITLPLLLKYRLNKYSGVP	109.37	gnl|BL_ORD_ID|1065|hsp_num:0	1092		
BGC0000804.1|Acarviostatin_14 # 21330 # 22355 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.703	BGC0000804.1|Acarviostatin_14 	21330	22355	+	Loose	650	124.79	tetA(58)	30.72	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGATCGTCGCACACGAACTGGTCAAGGAGTTCAAGATCCCGGAGCGGCGGCCGGGCCTGGCGGGCTCGCTCGCCACCCTCTTCACCCGCAGACACCGGGTGGTACGCGCCGTGGACGGCGTCTCCTTCGAGATCCCGGCCGGCTCACGCACCGCCTACATCGGCGCGAACGGCGCCGGCAAGTCCACCACCATCAAGATGCTCACCGGCATCACGACCCCCACGGCGGGGTACTGCCGGGTGCGCGGCATAGAGCCGTATCGCCACCGGCAGCGCAACGCCCGGTCCATCGGGGTCGTCTTCGGGCAGCGCAGCCAGCTGTGGTGGGACCTGTCCGTGCCGGACTCGTTCCGCATCCTGCGGCGGATCTACGACATCCCGGACCCCGTCTACCGGCGCAACCTGGCCCTGTACCGCGACCTCCTCGACATCGATGCGCTCGGGACCACACCGGTGCGGCAGCTGAGCCTCGGACAGCGCATGCGCGCGGAGATCGCGGCGAGCCTGCTGCACGACCCGGCGGTGGTGTTCTGGGACGAACCCACGATCGGGCTCGACATGGTGCTCAAGGAGGCCGTGCGCGAACTGGTCAACCACGCTCACCGCGAGCTGGGCACCACCGTCGTACTGACCAGTCACGACATCGCCGACATCGCGGCCATCTGCGACAGCGCCCTGGTGGTGGACCGGGGCCGGGTGGTGCATCAGGGCAGCATCCAGGACCTGTTGCGCTCGGCCGACCGGCGTGCCGTCCTCTTCGACCACCGCGACCCGATCGCGCCGGACACTGCCTGCGCGATCGTGGAGCAGGGACTGCCCGGGGTGCGGGCCACGGTGGTCGACGGCGGCCGCGTCCACGTCGACTACCCCGCGACGGAGTTCACCTCCCGCCGCGTACTCGCCTTCCTCCTGGAACGCTTCGACCTGGCCGACTGCTACGCGCCCGAGCCCGACCTCGAGGACGTGCTGCGCCAGATCTACGGGCAGCGACGTGACGCGGCCCTCCGTGAGGTGGACGCCGCGTGA	MIVAHELVKEFKIPERRPGLAGSLATLFTRRHRVVRAVDGVSFEIPAGSRTAYIGANGAGKSTTIKMLTGITTPTAGYCRVRGIEPYRHRQRNARSIGVVFGQRSQLWWDLSVPDSFRILRRIYDIPDPVYRRNLALYRDLLDIDALGTTPVRQLSLGQRMRAEIAASLLHDPAVVFWDEPTIGLDMVLKEAVRELVNHAHRELGTTVVLTSHDIADIAAICDSALVVDRGRVVHQGSIQDLLRSADRRAVLFDHRDPIAPDTACAIVEQGLPGVRATVVDGGRVHVDYPATEFTSRRVLAFLLERFDLADCYAPEPDLEDVLRQIYGQRRDAALREVDAA	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	99.42	gnl|BL_ORD_ID|2287|hsp_num:0	2517		
BGC0000804.1|Acarviostatin_15 # 22352 # 23176 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.705	BGC0000804.1|Acarviostatin_15 	22352	23176	+	Loose	2300	25.0238	evgS	28.33	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGCCACCCACGACGCGCGCGGTGCGGGCCTACCTCCCGTTCGCGACAGGAGGGCTGCAGTCACTTCTGCAGTACCGCTCGATGTTCGTGATCACCGGCATGACCGCGGCCGCGGGCGCGGCCGTCACCGTGTTCCTGTGGCGCGCCGTCTACGCGGACACTCCGGCGGACGGTGGGCCGGGCGGCTTCACCCTCACGGGCATCACCACCTACCTCCTGGTCGCGCAGGTGCTCCAGGTACTGCACACCAACCGGGTGGACGACGAGGTCGCCGCCGAGGTCTACCGCGGGGACGTGGCCGTGATGCTGGTGCGCCCGGTCAGCTATCCGCTGGTGCGGTTCTTCGCCAGCCTGCCGGTCGTCGCGGCGAACGCGGTGCTCGTCGCGGTGCCGGTCCTGGTCCTCTTCGCCCTCCTGGTACCTCTCACGGTGCCACGTCCCGGTGACGTGGCCCTGTTCGCGCTGTCCACCGTGTTCTCGGTGCTCATCGCGTTCTGCGTCAACCTGCTCACCGGCATGACCGGCTTCGTCACCACGAACACCTGGGGCGTCCGCATGGTCAAGCAGAGTGTGGTCGCCTTCTTCGCCGGGCAGTTGGTGCCGATCGCGCTGATGCCGCAGCCACTGGCGGCTCTCGCCCGTTGGCTGCCGTTCCGGGGCATGGTCGACGGCCCGCTCACGCTGCTCCTGGGCCGCTACGACGGCGCCGCCGGGGCACTGCAGGTCCTGGTGCAGCAGGTGGGCTGGGTCCTGGGGCTCGGGGCCATGTGTGCCGTGCTGTGGCGGGCGGCACTCGGCCGGCTGGAGGTGCTCGGCGGATGA	MKPPTTRAVRAYLPFATGGLQSLLQYRSMFVITGMTAAAGAAVTVFLWRAVYADTPADGGPGGFTLTGITTYLLVAQVLQVLHTNRVDDEVAAEVYRGDVAVMLVRPVSYPLVRFFASLPVVAANAVLVAVPVLVLFALLVPLTVPRPGDVALFALSTVFSVLIAFCVNLLTGMTGFVTTNTWGVRMVKQSVVAFFAGQLVPIALMPQPLAALARWLPFRGMVDGPLTLLLGRYDGAAGALQVLVQQVGWVLGLGAMCAVLWRAALGRLEVLGG	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	22.89	gnl|BL_ORD_ID|1243|hsp_num:0	1318		
BGC0000804.1|Acarviostatin_16 # 23173 # 23979 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.690	BGC0000804.1|Acarviostatin_16 	23173	23979	+	Loose	1900	25.7942	MexI	48.28	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGCACGGAGCACGGCGGCGCGGTACGCGCGTCTGTCCTGGTTTCTGGGCGGTGTCGGTCTGCACCGGCTCACCGCCTACCGGTTGGACTTCCTGCTCGGTGCCGGCGCGTTCCTGGTCCGGGTCGGGGTGCAGACGGCCGTGGTCGGCCTGGTGTTCCGGCAGGTGCCGGTGGTGGGCGGCTGGTCGTACCACGAGGTGGTGTTCCTGCTGGGCTTCTCCCTGCTGCCGCGGGGCCTCGACCATCTCTTCACCGACCAGCTGTGGGAGCTGAGCCGCAAGCTGGTGCAGCGCGGTGAGTTCTACCGGCACCTGGTGCGGCCGGTCAGCCCGCTGTTCTCACTGCTTTCCGAGCGGTTCCTGCACCCGGACGGGTTCGGCGAACTGATCGTCGGCGCGGCCCTCGTGGGCTGGTCCGGATCTCATCTCGACCTGGACCTGACCGCGGCCCAGTGGGCGCTGGCCCCTCTGTTGGTCCTGTGCGGAGCGCTGATCCACTCGGCGGTGAAGCTCCTGTTCGCCTCGCTGTCCTTCTGGACGGTCACCAGCCTGCCCGCCATGTACGCGGCCAACCAGGTCTCCGAGTTCACCTCCTACCCGCTGGACATCTACCACCCGACCCTGCGGGCCCTGCTGACCTGGGTGCTGCCCTTCGCCTTCACCTCGTACGTGCCCTGCACCTATCTGCTGACCGGCGACACCGGGCTGGTGGTGTGGCTGCCGGTGGTGACGGCGGGAGCGGTCGCGCTCGCACTCGCGGTGTGGCGGCGAGGTCTGACCATCCACGACACGACCGGGAGTTGA	MSARSTAARYARLSWFLGGVGLHRLTAYRLDFLLGAGAFLVRVGVQTAVVGLVFRQVPVVGGWSYHEVVFLLGFSLLPRGLDHLFTDQLWELSRKLVQRGEFYRHLVRPVSPLFSLLSERFLHPDGFGELIVGAALVGWSGSHLDLDLTAAQWALAPLLVLCGALIHSAVKLLFASLSFWTVTSLPAMYAANQVSEFTSYPLDIYHPTLRALLTWVLPFAFTSYVPCTYLLTGDTGLVVWLPVVTAGAVALALAVWRRGLTIHDTTGS	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	26.04	gnl|BL_ORD_ID|1553|hsp_num:0	1647		
BGC0000804.1|Acarviostatin_17 # 23986 # 25449 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.734	BGC0000804.1|Acarviostatin_17 	23986	25449	+	Loose	750	27.7202	MexE	35.71	3000803	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACGGTGCCGAAGCGGATGCGGGCCTGGACGGGCTGCTGCGCGCCGCCCCCTGGATGCCCGAGGACGCGCGCGCCGCCGAGCGTTTCGAGCGAATCGATCACGCGGTACTCGGCGGGGCGGCGTTGCTCCTGATCGTGGCGGCCGTCGGCGGTCCCGCGTCAGGTCGCCGGTTCTTCGTACCGGTGCGCGGAACCGACGGTGGCGGCTTCGAAGCGGCGCACGGCAGCGAGGCATTCGACGTCGCCGCGGTGACTCGTACGCTGACCGGCGGAAAGCTGCCTACAGCGCGAGGCGGGTCCGTCGAGTTCCGGGGACCCGGGCGCGGTCCGATCGGGGTGCGGCGCCTGCCGTTCGAGCAGGGCTGGTCCTCCAACGCGCTGTCGCTGGTGGACGTGTCGGGCACGGCCTGCATCCACAAGACGTACCGCCGTCTGGACGAGACCATCCACGAGCCGGAGCTGCTGCGCCGCATGAACGGCACCGGCCGCACCCCACAGTGGGTGGGCGACTACACGTACGTGGCGCCGGACGGCACGTCCCGCAGTCCGCTCGGCGTGATCTACCAGTACGTCCAGGGCGAGGGCATCGACGTCCCGCTGCGCGGGAACCTCCGCTCGATGTGGCCGCGGCTCTCGGGCACCACGTCCGTCGAGGAGGTCGTCCGCTCCCACCTGGGGCCGCTGGAAGAACGGTTGCGCCGGGCCTGCGAGTTCCTGGGCGACTTCCACCGGGACCTGGCACACCGGCTGGGCGGCGCCGCCGAGTATCCCGTGCGCGAGGCCCTGGACGACGCGGTGGACCGCGCCGACCGTCTCGCCCGGCACGGCACCGGACTGGCACTGCCGAAGTCCGCGCACGAGGCCGCCTTCGACGCCCTGCACACAGAACTCGCCGCGCTCGCGGCGGAGTTCGACGACGGGAACATTCCCGCATCCGGACCCTGCCACGGTGACCTGCACCTCTCCCATCTGCTGTGCGCGGCCGACGGCGACAGGGGGGCCGGAGCCGGCTGGCGCATGACGGTGCTCGACCTGTCCACGCCGGCGCTCGGCCCCGACGACCCGGACTGGCCCCGGCAGTCGCCCCTGCAGGACCTGGTCGCTCTCGAGCGCGCTCTGGAGTACTTCGCGGCCGACGAGGCGGCGTTCGAGGCCGCGCGGCGACTCGGCGTGGACTCGCTGGAGACGATGCTCGGCTCTCTGGACGGCGCTCCGCACTGGCCCGAAGCCCGGCGGGCGGTGCTGCGGCAGGTGTTCGCGGCGGCCGACGCGTGGCGGCGGCACGTGACGCGGCTGCTGCTCGGTTCCGCCTCCGACCACCCGCTGCGCCGCCTGCTGTACGTCCGCAGGCTGCTGCACGAGCTCACCTACAACCAGGCCCATGCCCGCCCCTACCACGCGGCGATCGACCTGCGTCACGCTCGCGCGCTCGCGCCGGCCGCCGCGTTCGCGAGGAAGTGA	MHGAEADAGLDGLLRAAPWMPEDARAAERFERIDHAVLGGAALLLIVAAVGGPASGRRFFVPVRGTDGGGFEAAHGSEAFDVAAVTRTLTGGKLPTARGGSVEFRGPGRGPIGVRRLPFEQGWSSNALSLVDVSGTACIHKTYRRLDETIHEPELLRRMNGTGRTPQWVGDYTYVAPDGTSRSPLGVIYQYVQGEGIDVPLRGNLRSMWPRLSGTTSVEEVVRSHLGPLEERLRRACEFLGDFHRDLAHRLGGAAEYPVREALDDAVDRADRLARHGTGLALPKSAHEAAFDALHTELAALAAEFDDGNIPASGPCHGDLHLSHLLCAADGDRGAGAGWRMTVLDLSTPALGPDDPDWPRQSPLQDLVALERALEYFAADEAAFEAARRLGVDSLETMLGSLDGAPHWPEARRAVLRQVFAAADAWRRHVTRLLLGSASDHPLRRLLYVRRLLHELTYNQAHARPYHAAIDLRHARALAPAAAFARK	MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG	117.63	gnl|BL_ORD_ID|1066|hsp_num:0	1067		
BGC0000804.1|Acarviostatin_18 # 25457 # 27544 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.705	BGC0000804.1|Acarviostatin_18 	25457	27544	+	Loose	500	26.5646	CTX-M-144	24.05	3002002	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGAACCGCGTATGCACATCATCGAGACGTACTTCGAATGCTGCGGCTTCGACCACACCTTCATCCAGGGCGGCACGTCCGTCTATCTGTGGAATCTGTCGAAGAAGTTCGCCCAGAGCGGCCACCGGGTCTCCATCGTGACCCCGGCCCACGGGCGCCTCGACGACCTGCGCACCCGTTACGAGGTCGAGGACCTGCCGTACGAGGACGCGTACACGCTGCCCGTCCCGCTCGACCCGGAGGTGTGGCGGGACTTCCCCGCCGAGGCCGCGCTGGCGCTCACCACCACCGCGCACCGCATCCGCCTGGACGGCGTCGACCTGTACTTCCTCGCCAACGACTGGCTGAACCGGCTGCCGGACACCTTCTACCCGCCGTACCAGAGCAAGGGCAGCGACCTGGTCTTCTTCAAGCCCCTGGTCTTCCAGGTGGACGCGGTGCGGTTCCTGCGTACCCGGTTCGGTGACGAGAAGGCGCTCGTCCACGCGCACGAGCCCTACTACCACTATCTGCTGCCCGCGGCGCTGCGCGACGACCCTTCGAAACTGGTCGTGAGCAACGTGCAGAGCAACATGCCCATCGCGAAGAAGGTGTACGAACCCGAGGTGCGGCGGTTGCTCGAACTGCTGGGTGCTCCGCTTCCGGCGCGTGCTCCCGAACCGCCCGTCGCCGCGCCCGCGGCCATGGTCCAGTACCAGCAACTCACCCATCTGCACTACGAGTACGGGCCGGACAACCTCGCCGTCTACGAGCTGACCGCCGACCACTCCGATCTGATCGACTTTCTCTCGCCGGGCCAGCTGGACTTCTACGCCGGTTTCCGTGACACCCCGTTCGAGGATCTCTTCGGACGGCTGCCGATCGCCGACGTGGTGCGTCGCAACGCGCACAAGATGTTCGTCGGCGGCTGCGCCGTCTCGGACCAGTGGCTGGCCTGGGACCCCGCCGGAGTCGACCGCACCGAGGTGCTCGAAGGGCTGGGCCTGGACCCGGACCTGCCGGCCTTCTTCCACAACGCCCGCTACGCCGTCCACCACAAGGGTCAGCTGGAGCTGGTCCGCGCCGTCGACCGGGTGCTGAGCGAGGGACTCGCGGCCAGCTTCGTCATCCGCTGCATCTCCGGCAGCGGCATCGACGACCCGTTCTTCCACGAGGTCGCCGCCCGGCACAAGGGGAGGCTGCACCTGGAGTGGGAACGGGTCCCGGAGCGGCAGGTGTTCGGGTACGCGGCCGCCTCCGACTTCTGCCTGTTCCCCTCCAAGTTCGAGATGGACACGTTCCTCATCGCACAGGGCGAGGCCATGGCCGTCGGCTCGGTGCCGATCGCCACGGACCAGCGGGGCATGGCGCACTTCGGACACGCGGACCCTCCGGACTCCGCCACCGGCTTCGCCGTGAACCGTTCGTTCGCCGAGGACGACGAGTTGCTGGTCGCCGCTCTCGCCGCCCGCATCCGTCAGGCGGCCTCCCTGTGGCGGGAGGAACCCGAGCGGTACCGGGAGCTGGCCCGGCGGGCGTCCGCCGTCGCCCGAGTGTTCACCTGGGCCCACTGCGCCGATCTGCACCTGACGGAGTTCGCCCGGCTGTGGCAGGGCGAACCCCCTCGGCTCGATCCCGAGCTCGCCCTGCGGCACGGCTGGTTCGACCTGGTGGAGGACCCGGCACGCACTGCGGAGGCGGCCCTTGCCCGCGGTGATGTGGACGCCTACGAGCGCCGTGCGCCACTGGACGACGCCGCGGTCCGGCAGTTGTTCGACGCGGCCTGGGCACGCGCCGACTTCGCCGCGTGCGAGCGCGCCGCGGAGCGCGGCCGGCCGGGCGTGATCGGCGCCGACGACCTGACTCGGCTGCGCACGCGCGCCCGCCTCACGCCGGACGGCTCCCTGCTCTACCGGCTCCCGCAGGCGGTCCGGGTCGAGGTCGTGTCGCCGGCCTCCGACAGCGGCCCGCGGGCGCGGCCCGGCGTACGCGCTCTGGAACGCACGGCCCCGGGCACGTTCACGGGTCCGGCACCCGGGCCGGGCGCGCTGCTGCTGCTCACCCTGGACTCCGGTCGCGTGGTCTGGGACGAGGTGCGCCGTGGCTGA	MEPRMHIIETYFECCGFDHTFIQGGTSVYLWNLSKKFAQSGHRVSIVTPAHGRLDDLRTRYEVEDLPYEDAYTLPVPLDPEVWRDFPAEAALALTTTAHRIRLDGVDLYFLANDWLNRLPDTFYPPYQSKGSDLVFFKPLVFQVDAVRFLRTRFGDEKALVHAHEPYYHYLLPAALRDDPSKLVVSNVQSNMPIAKKVYEPEVRRLLELLGAPLPARAPEPPVAAPAAMVQYQQLTHLHYEYGPDNLAVYELTADHSDLIDFLSPGQLDFYAGFRDTPFEDLFGRLPIADVVRRNAHKMFVGGCAVSDQWLAWDPAGVDRTEVLEGLGLDPDLPAFFHNARYAVHHKGQLELVRAVDRVLSEGLAASFVIRCISGSGIDDPFFHEVAARHKGRLHLEWERVPERQVFGYAAASDFCLFPSKFEMDTFLIAQGEAMAVGSVPIATDQRGMAHFGHADPPDSATGFAVNRSFAEDDELLVAALAARIRQAASLWREEPERYRELARRASAVARVFTWAHCADLHLTEFARLWQGEPPRLDPELALRHGWFDLVEDPARTAEAALARGDVDAYERRAPLDDAAVRQLFDAAWARADFAACERAAERGRPGVIGADDLTRLRTRARLTPDGSLLYRLPQAVRVEVVSPASDSGPRARPGVRALERTAPGTFTGPAPGPGALLLLTLDSGRVVWDEVRRG	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDLRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	238.83	gnl|BL_ORD_ID|1667|hsp_num:0	1768		
BGC0000804.1|Acarviostatin_19 # 27594 # 28658 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.705	BGC0000804.1|Acarviostatin_19 	27594	28658	+	Loose	1200	25.409	tetB(P)	27.27	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGGGCCGCTCGGCACCGGCCGCCTCAAGCCGCTGATCCCCTACGGCGGCGCCTGCCGGCTCATCGACTTCAGCCTCGCCAACGCGCACCGGTCCGGGCTGGGCGAGGTGTTGCTGCTGTCGCAGTTCGAGGAGCGGCAGCTCATGGACGACCTGCACCAGGTGTGGAACGCCCGGCCCGGCCTGCGGGTGCACTTCGGGCCGTACGACTCCGCCTACCGGGACGCGCCCGCCGGCCTCCTTCCACGCCGCCTCCCGCCCCGCTCCGGGGCACCGGAGCGGGGCACGGCCGATGCTCTGATCCGCAAGGCGCCCTACATCTTCGGCCCGGGCACGGAACAGGTGCTCGTGCTGCACGCCGATCACGTCTACCGCTTCGACTACGGCCCTCTCATCGCCTCGCACAGGGCGTCGGGAGCCGCCCTGACCATCGCCTACCAGCGCATCGAGCGACGTTGGGTGCATCTGTTCGGGATGGTCGACTTCGACGCGGACAACCGCCTCACACAGTTCGTCGAGAAGCCCGAGCAACCCACCTCCGACCTGGTGTTCGCCGCGTTCTGCGTCTTCGACGCCGAGGTGCTCCACCGCCACCTCGAACAGCTCGAGGGCACCGACTGGCAGCACGACATCAGCCGCGACGTCATCCCGGCCATGCTCGCCGCCGGCGAGGACATCCGCGGCTACGAAGTGCACGGGCACTGGGCGGACATCGGCACCGTCGAGCGGTACCACCGGGCGCACCTGGCCCTCGCGGACCATCCGCGCGCCGGTCTCCCGGCGGACCGGATGCCGTGCACCGTGCGCCCCGACGTGCGGCGCGCCTGGATCTCCGACTCCCCCGGCGTTCGTTCGTCCTGGGTGCCCCAGGATCTGGTCAACGAGGGGCAGGTGGAACGCAGTGTGATCTTCCCCGCGGTCCGGATCGGTGCGGGCGCCAGGGTGCGTCGCAGTGTCGTCCTTCCGGGTGCCGCTGTGCCCGCGGGCGCCGACATCGATGCGTCGGTCGTTCTGGAGAACGGGACGATCCAGCCCATAGCGCGGACAGAAGGAGTACTGACGTGA	MGPLGTGRLKPLIPYGGACRLIDFSLANAHRSGLGEVLLLSQFEERQLMDDLHQVWNARPGLRVHFGPYDSAYRDAPAGLLPRRLPPRSGAPERGTADALIRKAPYIFGPGTEQVLVLHADHVYRFDYGPLIASHRASGAALTIAYQRIERRWVHLFGMVDFDADNRLTQFVEKPEQPTSDLVFAAFCVFDAEVLHRHLEQLEGTDWQHDISRDVIPAMLAAGEDIRGYEVHGHWADIGTVERYHRAHLALADHPRAGLPADRMPCTVRPDVRRAWISDSPGVRSSWVPQDLVNEGQVERSVIFPAVRIGAGARVRRSVVLPGAAVPAGADIDASVVLENGTIQPIARTEGVLT	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	54.29	gnl|BL_ORD_ID|758|hsp_num:0	804		
BGC0000804.1|Acarviostatin_20 # 28655 # 29581 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.713	BGC0000804.1|Acarviostatin_20 	28655	29581	+	Loose	1190	26.1794	novA	61.11	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCGTTTCCTCGAGCATGTACGACATCCTGGTGGCGGGCGGGGCCGGTGTGGACACCATCGTCCGGGTGCCCGAACTCAGGGTGCCGCCCGGCGACTCCGTGTTCGTACCACCGGTGCGTGACTACGTGGCTCACACCGGCAACGGCGTCGCCCGCGGCACGCACGCCCTGGGGCTCACCACCAAGTTCATCGACTTCCTCGGCGCCGACGCACAAGGCCACCAGATCCTCGCCGCGTACGCCACGTCCGGGCTCGACTTCAGTCACGTCGTCTCGCCGCACGGCACTCCGCGCGGGGTCAATCTCGTCGACGCGCAGGGGCGGCGCTTCTCCTTCTACGACGGCCGCCATCCGGCCGACCTGCGGCTGCCCCGCGCCTTCTACCTGCCCTTCCTGGAGCGGGCCCGGCACGTGCACCTGTCCATCACGGGCGTCACGCTGGACATGTATGCCGACATCCACCGCCTCGGCGTCCCCTGCTCCACGGACCTGCACGACTGGGACGGTGCCAACCCGCACCACCTGGCCTACGCCGTCGCCTCCGACTACGTCTTCATGAGCGCCGCGGCGGTCCACGAACGTCTCGACGAGGTACTGCGTTCCATCCTGGACCGGGGCCGCGCGCGCCTCGTCGTCGCCACCGACGGGGCAGCCGGCTGCCACGTCCTCGAACGCGGCGACACGAGCGTGCGGCGCTACCCCGCCGTAAGACCGGAGCGTCCCGTCGTGGACAGCAACGGCGCCGGGGACGCGTTCGTGAGCGCGTTCCTGTACGCACTCGCGCAGGGAAGGCCGGTGGCCGACTGCGTGCTCGCCGGATCGGTGTCCGGAGCGTTCGCATGCACGAGCGCGGGCACGCACACCGAGTTCATCGACCGGGACGGGCTGCGGGCGGGCTGTGCGCGCGCCGGGGCCGACGGCTGA	MTVSSSMYDILVAGGAGVDTIVRVPELRVPPGDSVFVPPVRDYVAHTGNGVARGTHALGLTTKFIDFLGADAQGHQILAAYATSGLDFSHVVSPHGTPRGVNLVDAQGRRFSFYDGRHPADLRLPRAFYLPFLERARHVHLSITGVTLDMYADIHRLGVPCSTDLHDWDGANPHHLAYAVASDYVFMSAAAVHERLDEVLRSILDRGRARLVVATDGAAGCHVLERGDTSVRRYPAVRPERPVVDSNGAGDAFVSAFLYALAQGRPVADCVLAGSVSGAFACTSAGTHTEFIDRDGLRAGCARAGADG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	50.08	gnl|BL_ORD_ID|1140|hsp_num:0	1210		
BGC0000804.1|Acarviostatin_21 # 29599 # 32682 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.723	BGC0000804.1|Acarviostatin_21 	29599	32682	+	Loose	400	27.335	vanRC	28.57	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGCACATCATCACCTTCTCCTTCGAATGCGGCGGCTTCGACCCACGCCTGATGCGCGGCGGACTGTCTCCACTGGTGTGGCAGCTCTCCCGCCGTTACGCCGCGCAAGGCCACCGCGTCTCGCTGGTCACGCCGGGACACGGGCACGTGGACCGGCTGCGGGCCGCCCACGGCATCGAGGACCTGCCGCACCTCACCCGCACCCGCACGGTGCCTCTGGCGCTGGATCCCGAGGTCTGGGCCTCATGGCCGGCCGACCTGGACGTGGACGTGACGACCACGGTGCACCGGCTGCGTCTGGACGGCGTGGACGTGTACTTCATGTCCAATGCGTATCTCGACCTGCTGCCCGACCGGCTGTATCCGCCACCGGGCGTCGAGGGCAGGGACCTCTCCCACTTCAAGCCGCTGGTGTTCCAGGCCGAGGGACTGCGGTTCGTCCAGGAGTACCTGCGGTCGGAGGACGAACCCGCCGTGGTGCACGCCTTCGAACCCGCCTATCACTACCTCTTGCCCCCGGTTCTCGCCCCCGATCCATTCCTCCACACGGTCAGCACCGTCGCCGCGAATGCCCCGATCGGGCAGAAGGTGTACCGGCCCCAGGTGACGCGGATGCTGAAGCTGTTCGGCGTGGCCGACGTGGACCTGGACGCGCTGGACGGCCCGCCGCCCGAGGAGCGCTCGACACGGGCGGTACTCTCGCGCGCCCTGGCCGGGACCCGGATGCACGTCGAGTACGGCCCCGACCACGTCGGCCTGTTCCCGTTGATAGCCGCCCACGCTGATCTGGTCGACTTCGTGTCGCCGGGACAGCGCGCGTACTACAGCACATTCCGGGACACGCCCGTGCAGGCGCTCTTCGAGACGCTGCCGGTGGCCCGGACGCTGCGGCAGCGCGCCGACCGCGTCATCACCGGTGGCTGCGCCGTCACGGACTCCTGGCTGGCGCGCGACACGACCTCGGTCGACCGGCACCAGGTGCTGCGCCGTCTGGGTATCGATCCGGCACTTCCGGTCTTTTACCACGCGGCGCGCTACGCGGTGCACCACAAGGGCCAGTTGGAACTGATGCGGGCTATCGAGGAACTGCTGGACGACGGAGTGGAGGCCGGGTTCCTGCTCCGCTGCTCCACGGGAGACGGCGCCGCGGCGAACGCGTACTTCCAGTCCGTGGCCGACCGCCACCCCGACCGGCTCCGGCTCGCGTGGGATCTCGCGGACGAGGACACCCTCTTCGAGGAGGCGGCGTGCGCCGACTTCTGCGTCTACCCGTCCAAGTTCGAATTGGACGGCTTCCTCATCGCGCAGGCCGAGGCGATGGCCTGCGGGGCCGTGCCGATCGCCACCGACCAGCACGTCACCCGGCACTTCCGGCACGCTCTGCCGAGCGGACATCCCGAGGCGACGGGCTTCTCGGTGCCCGGCTCGTTCCACGACGACGACCCGGCGCTCGCCCGCGGCCTGGCCGCGCGGATCCGCACGGCGGTCGGTGTCTTCGCCGCGCACGTCGACGGTTCCGACCCCACCTATGCCCGGCTGTCCGCCAACTCGCGCGCCCTGGCCCGGAGGTTCACCTGGGAACGCGCCGCGCGCACCCGGCTGGACGCCTTCGAGGGGCTTCTCCATGGCCGGGTCCGGCCGTTCCCCGTGCGCGAGGCGATCGCGTACGGCTGGTTCGACGACCTGCCCGCGAGCGCCTGGGACCAGCACCCCGAGGAGATCCGGGAGGCGGCGCTCACCCGCGGGGACCTCGGCGCGTGGGAGCGCGCGGGCGGGGCGGTGGACGCGCAGGCGTGTGAACGGCTCTTCGAGGCCGCGTGGCGGGAGGCCGAGTTCACCACCGCGCTGCACAACGCCGTGGTGGCCGGACGCTCCGACCTGACCGCCCGGGTTCACGACCGGGGCACCGTTCGACGTACGGCGAACGGCCGGTGGGAGGTGACGTACCGGCACGAGCACGTGGCTCGGGTGGAGGCCGTGCTGGAAGGTCGGAGGGGCGCTTGCACCGGACCGGACGCCGTCTCGGGCGGCTCCCGGCCGGCCGCGGGCGAGACCGCCGCGGAGGCCCTCGCGTCCGACGAGCCGGTGCCCCCCGGCACCGGCGCCGTGTTCCACGCCCTGTCTCCGCAGGACGGTCGGCCCGGTTCCTTCCGGGCCGTACTCGACGCCGCTCCGGCGGGGCGCGACCTGTCCGTCATGCTCACGCTGGCCTCCGGTCACGTCCGCTGGGACACCCTGCCGCTGCGGCGGCCACCGTTCCGGCTGGTCGCAACCGATCTAGACGGGACCCTGTTGCGTGACGACCTGACCGTCTCTCCACGAACCCGTGCCGCCCTCGCGGCGGTGACCGACGCGGGAGCGCACCACCTCGTGGCCACCGGACGCCCGGCCTCGGCCTGCGCGCACATCCTCGACGCCCTCGGATACCGCGGTCTGGCCGTCTGCGGACAGGGCGCCCAGCTGTACGACGCCGGCTCGCGACGGCTGCTGTCCTCGGCCTCCCTCGGCCGTACGCTCGCACGCCGCGTCGTGGCGGGCGTGGAGGAGAGGCTCGGTCCCGTCGAGCTGGGCGTCGTCACGGCGCCGCCGGACAGCCGGTTCAAGGTGACCGAGGGGTTCGGGCAACGTGTGCGCCACGGCTGGGACGTGACCACCGACCGGGACCTGTTGTGGGACAGTCCCGTCGACAAGCTGATCCTGCACCACCCCGAGGTCGACGAGGACCGGCTGGCCGCGCTCACACAGAGTCTGTTCGGCGACGAGGTGACGGTCGTCCACTCCGTGAAGGGCATGGTGGAGGTGCTGCCGCCGGGTACGACCAAGGCCGCCGGGGTCGAGCGCGCCGCCCGGCTGCTCGGCTGCGCCGCGAGCGACACCATCGCCTTCGGCGACATGCCCAACGACATCCCCCTGCTCACCTGGGCGGCGCACGGCGTCGCCGTGGCCAACGCCCACCCGGCCCTGCTCGCCGCCGCCGACGAGATCGCACCGCCCAACGAAGAGGACGGGGTTGCGGTGGTCCTGGAGCGGCTCTTCACCCCCGGGGCGCAGAACCGCCGCACCCCCTCCGAACGTCACGCATGA	MHIITFSFECGGFDPRLMRGGLSPLVWQLSRRYAAQGHRVSLVTPGHGHVDRLRAAHGIEDLPHLTRTRTVPLALDPEVWASWPADLDVDVTTTVHRLRLDGVDVYFMSNAYLDLLPDRLYPPPGVEGRDLSHFKPLVFQAEGLRFVQEYLRSEDEPAVVHAFEPAYHYLLPPVLAPDPFLHTVSTVAANAPIGQKVYRPQVTRMLKLFGVADVDLDALDGPPPEERSTRAVLSRALAGTRMHVEYGPDHVGLFPLIAAHADLVDFVSPGQRAYYSTFRDTPVQALFETLPVARTLRQRADRVITGGCAVTDSWLARDTTSVDRHQVLRRLGIDPALPVFYHAARYAVHHKGQLELMRAIEELLDDGVEAGFLLRCSTGDGAAANAYFQSVADRHPDRLRLAWDLADEDTLFEEAACADFCVYPSKFELDGFLIAQAEAMACGAVPIATDQHVTRHFRHALPSGHPEATGFSVPGSFHDDDPALARGLAARIRTAVGVFAAHVDGSDPTYARLSANSRALARRFTWERAARTRLDAFEGLLHGRVRPFPVREAIAYGWFDDLPASAWDQHPEEIREAALTRGDLGAWERAGGAVDAQACERLFEAAWREAEFTTALHNAVVAGRSDLTARVHDRGTVRRTANGRWEVTYRHEHVARVEAVLEGRRGACTGPDAVSGGSRPAAGETAAEALASDEPVPPGTGAVFHALSPQDGRPGSFRAVLDAAPAGRDLSVMLTLASGHVRWDTLPLRRPPFRLVATDLDGTLLRDDLTVSPRTRAALAAVTDAGAHHLVATGRPASACAHILDALGYRGLAVCGQGAQLYDAGSRRLLSSASLGRTLARRVVAGVEERLGPVELGVVTAPPDSRFKVTEGFGQRVRHGWDVTTDRDLLWDSPVDKLILHHPEVDEDRLAALTQSLFGDEVTVVHSVKGMVEVLPPGTTKAAGVERAARLLGCAASDTIAFGDMPNDIPLLTWAAHGVAVANAHPALLAAADEIAPPNEEDGVAVVLERLFTPGAQNRRTPSERHA	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	444.59	gnl|BL_ORD_ID|1455|hsp_num:0	1547		
BGC0000804.1|Acarviostatin_23 # 34800 # 35981 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.689	BGC0000804.1|Acarviostatin_23 	34800	35981	+	Loose	700	28.4906	mgtA	37.84	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGTCAGGCCAGGTTCTTGCCCCGGTCGAGCCGGGCGTGCGCGAGGACGCCACCGGCTTCGACCTGCTGGCGCCCGAGGGCACCGCCTACCGCGTGGACCTCACCACAGGGGTGTTCGACCAGGAGAATCCGCTCCTCGCGCGCGCACTCATGGGCCGCAGGGTCGTCGCATTCGTCAGCCCCACGATCGAGGGACTGCACGGTGACCGGCTGCGCGCCTATCTCAACGCCCATGTCGATCCGGGGGACTGGAGTGTCCACACGCTGCGGACCGGCGAGCAGCACAAGACGCTCGCCGCCGCGGAGGACGTCTGCGCCACCGCCAAGGCCGCCGGACTCGACCGTCATGGGGTGATGCTGGCGGTGGGCGGCGGAATAGTCGCAGACGTCGTCGGCTTCGCCGCGTCCATGTACGCGCGCGGTGTCCGCTACGTCAAGGTCAACACGACGCTGGTGGGGCAGGTGGACGTCGGTGTCGGTGTGAAGACCGGTGTCAACGCCCTGCGCACGAAGAACATGCTGGGTGCCTACCACCCGGCTCACGCCTCCATCAATGATCCCGCGTTCCTCACCACGCTGCCCCCGCGTGAGATCCGCTGCGGACTCGCGGAGATCGTGAAGATGGCGGTGATCCTGGACGAGGAGCTGCTGCGGACCCTTGAGGATCACCCGGACGTCTTCCTCGGCCGGCCGTCCGCCGACGGCCGGCTGGAGGAGTATGTGCTGCGGACGTCGATGCGCCTGATGATGGAGGAGCTCTGCCCGAATCTCCGCGAGCACGAGCTGGCGCGCCTCGTCGACTTCGGGCACACCTTCAGTCCGGTGATCGAGACGGCCGGCAACCACCGCCTCGAGCACGGGGAGGCGGTCGCCGTCGACATGGCCCTCTCGGCACACATCGCACGGCTGCTCGGGCTGGCGGACGCGGACACGTGCGAGCGGATCGTGCGCCTGCTGCGGCGCATCGGGCTTCCGGTCTTCGACACCCTCACCTGCACACCCGAACTGATGAGCCATGCGTTGCGGGCATCCTGGGAGCGGCGCGGGCGCAAGCTGCACCTGGTCGTGCCGACGGCACCGGGCAAGGCGACGTTTGTCGAAGAGCTGGGGGACGTCCCCGAGTCGTTGCTGCGCACGGCTCTGTCAGCGCTGGCGCGGGATACGGAGGGGCACCATGTCTGA	MSGQVLAPVEPGVREDATGFDLLAPEGTAYRVDLTTGVFDQENPLLARALMGRRVVAFVSPTIEGLHGDRLRAYLNAHVDPGDWSVHTLRTGEQHKTLAAAEDVCATAKAAGLDRHGVMLAVGGGIVADVVGFAASMYARGVRYVKVNTTLVGQVDVGVGVKTGVNALRTKNMLGAYHPAHASINDPAFLTTLPPREIRCGLAEIVKMAVILDEELLRTLEDHPDVFLGRPSADGRLEEYVLRTSMRLMMEELCPNLREHELARLVDFGHTFSPVIETAGNHRLEHGEAVAVDMALSAHIARLLGLADADTCERIVRLLRRIGLPVFDTLTCTPELMSHALRASWERRGRKLHLVVPTAPGKATFVEELGDVPESLLRTALSALARDTEGHHV	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	94.02	gnl|BL_ORD_ID|2357|hsp_num:0	515		
BGC0000804.1|Acarviostatin_24 # 35974 # 36390 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.731	BGC0000804.1|Acarviostatin_24 	35974	36390	+	Loose	500	23.8682	AxyX	29.23	3004143	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTGAGGCCGTGGACGGCGGGGCGGTGCGCAATCTGCGCGAACTGTTCGCGCCCAAGGAACACGACCACGGTGGCCTCGGCACCATCCTGGCGCACCGGGTCTACGCCCGTCGGAGCGGGCGGCGCGGGGCCGAGTTCGTCGATCTGGCCGTACTGCCGCCCGGCACCTCGATCGGCCGGCACCGGCACGGCGCCGACCGGGAGACGTATGTCGTACTCGACGGCAGCGGGTTGATGTTCCGGGACGGCGAGCACTTCCCGGTCGGCGCGGGCGATGTGATCGCCAATCGCCCGTTCGGCGAGCACGGCCTCGTCAACGACGGCCCGGGGGATCTGCGACTGCTCGTGTTCGAGGAGCCGGAGGCGGCGCGGCCGCGCACCTCCCCCGCCGCGTCCGGGGAGGCGACGGCGTGA	MSEAVDGGAVRNLRELFAPKEHDHGGLGTILAHRVYARRSGRRGAEFVDLAVLPPGTSIGRHRHGADRETYVVLDGSGLMFRDGEHFPVGAGDVIANRPFGEHGLVNDGPGDLRLLVFEEPEAARPRTSPAASGEATA	MTHRVPFRTLAFASVLVLVSACSKQEAPEAAKAPAEVGVIVARATPTAVASELPGRLEPYREAEVRARVAGIVTRRLYEEGQEVTRGTPLFQIDPAPLQAAYDSEAAALARAQANLSAAADKLRRYADLVSDRAISERDHAESVAQERQARAEVALAKANLQSARLRLEYARVTSPIDGRARRALVTEGALVGEGQATPLTVVQQLDPIYVNFSQPAAEVMQLQKQIRAGALQGVAPDKMRVRLLLPDGSEYGQGGTLSFADLAVDPGTDNVTMRALFANPGRELLPGMYVRVRLEQAVNRDTFLVPRNALLRNADGAHVLVAGDDGELRSVAVTAHRLLGPNWVVTEGLAGGERVVVENAAQLAPGQKIKPVERTAPSAPVATAGNNEKR	35.29	gnl|BL_ORD_ID|2476|hsp_num:0	2797		
BGC0000804.1|Acarviostatin_25 # 36387 # 37439 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.737	BGC0000804.1|Acarviostatin_25 	36387	37439	+	Loose	800	26.1794	PDC-55	30.38	3005039	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGAACGTCATCGACACCGAGGCTCCTTTCGTCGTGGTGGACGTGGGCGGCACCACCCTGCGCATCGCGGACTACGATCCGATGACCGGCGCCCTGTCCGGTACACGCCGCACGCCCGTCGATGGCATGGCCCGCGACCCGAACGCTCCCGTGCCCGTGCTGCAGGAACGCGTCGTCGAACAGTTGGCCCGAGAGATCGGTGCCCGAACCGCGCGGGACGGCGGCCGTTGCGCACCGCGCACCGTCGGCGTGGCCTTCGCCGGGCCGGTCACCGCCGACGGCCTCGTTCTGGCCGCCCCCACGGTCTGGGGCGGACGGAGCGAGCCACTGCCCCTCGGTGCCCTGCTCACGGCGCGCGTCGGCGCCCCGGTCGTCGTCGTCAATGATCTGACGGCTGCCACCTGGCGCTACGCCGCCACCGAGAGCCGGCCCTTCTGCCTCATCACGGTCAGCTCCGGCATCGGGAACAAGGTCTTCCGCAACGGCGAGGTCCTGCTGGACCCGGGCGGCCACGGCGGGGAGTTGGGGCACTGGACCTACGACGCCTCCCCTGACGCCCTGCCGTGCGACTGCGGGGGCCGCGGCCACCTGGGGGCGATCGCCTCCGGCCGCGGTGTGCTCGCCGCCGCGCGACGGGCCGCGGTGACCGACCGGGGGGCGTTCGCCGCCTCCCGGCTGTCGGCTCTCGCCCACGGCCGTCCCGAGGCGATCGACAACCGTGCCATCGCCTCGGCGGTTCGGGCGGGCGACGCCTTCGCGACTGCCGTCCTGCGCACCACCGTCACTCCCCTCGCCCAGGCGATCGGGTCCGTCTTCACTTCGATCGGCATCTGCCGCTACCTCTTGATGGGCGGCTTCGCGCTGGCCGTCGGTGAGCCCTACCGCAGGCTGCTGGTGGCCGAGTTGACCCGGCTCGGCTGTTTCGGTCTGGACGCGGACGCCATCGACGCGATGGTGGCGCTCGGTGCCGCCGATGACGATCACGGCCTGCTGGGCGTCGGCCGCCTGCTCGGCGCGCGCCTGCCCGCCGGGGCCGGGCAGGTGGTCGGATGA	MNVIDTEAPFVVVDVGGTTLRIADYDPMTGALSGTRRTPVDGMARDPNAPVPVLQERVVEQLAREIGARTARDGGRCAPRTVGVAFAGPVTADGLVLAAPTVWGGRSEPLPLGALLTARVGAPVVVVNDLTAATWRYAATESRPFCLITVSSGIGNKVFRNGEVLLDPGGHGGELGHWTYDASPDALPCDCGGRGHLGAIASGRGVLAAARRAAVTDRGAFAASRLSALAHGRPEAIDNRAIASAVRAGDAFATAVLRTTVTPLAQAIGSVFTSIGICRYLLMGGFALAVGEPYRRLLVAELTRLGCFGLDADAIDAMVALGAADDDHGLLGVGRLLGARLPAGAGQVVG	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKRAREGDGA	86.63	gnl|BL_ORD_ID|2830|hsp_num:0	3782		
BGC0000804.1|Acarviostatin_26 # 37436 # 38410 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.724	BGC0000804.1|Acarviostatin_26 	37436	38410	+	Loose	750	27.335	cmlA9	32.39	3005043	protein homolog model	n/a	n/a		antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCACCGTCCTGGTGATAGGCAGCGGCTTCGTCGGTACCGGCATCGCCCGGCATCTCGCAGCCCACGGGCACACCGTCACCCTGGCGTCGCGCGGCCGGCCCTCAACGTCGCCCACGACGTACGGGGCACGCTGGGCGGCGCTGGACGCCACCGTCCCCGAGGCGTGCGACAGGCTTCTGACCCGACTGCGTCCCGACGGCGTGGTCCTGGTGCACGGCCCGTCCGACGTGACCTGGTGCGAGGAGCATCCGGGTGAGGCCGAGCAGGCTCACGCAGCGGTAGCGGGCAACGTGGCATCCCTGGCCCCGGGGGCCCGTGTCGTGCTCATCTCCACGGACAACGTCTTCGACGGCTCCTTGCCGCACAACACCGAGTCCACGCCGGTACGGCCCGCGAACGCATACGGCCGCGCCAAGCTCCGTGCCGAGCAGATCCTGCTGGCCACGGCGGCCGACGCCGTGGTGCTGCGCGTGAGCCTCGTCTACGGCCACGAGCCGGCGGGCGCGGGGAAGTGGCTGAACTTCTTCGCGTCCTGCGCTCATCAACTGTTGCTGGGTGAAGCGGTGCACGCGCCCGACGACCATTGGACGACCCCGGTGACCGTCTCCGACGTGGCCCGGGTCACCGCCTCCGTGCTCTTCGCCCCTGCCCCGCTGCCCGAGGTCCTCCACCTCGGCGGTCCGGACCGGGTCACCCGGGCCGAGTGGGCGCTGACGATCGCCGACCTGCTGGGCGCGCCGCGGAGGTTGGTGGTCCCGGTCCCGAAGGCCGCGACGCGGTACGCCTCCCGGCCCGAGAACGCGTGTCTGACAAGCACGTCGCTGCCCGGCCTGCTCGGTCTGATCCCGGTCGACGGTGTCGCCGCCGGGGCGCGAAAGCTCGTCACCGCTTTCACGGGGCGCCACGCGATCAGCCGGACACCTCCGGGGACAGGGCCGGTGTCGACGGAACCGGACCGGGAACGCGGGTGA	MSTVLVIGSGFVGTGIARHLAAHGHTVTLASRGRPSTSPTTYGARWAALDATVPEACDRLLTRLRPDGVVLVHGPSDVTWCEEHPGEAEQAHAAVAGNVASLAPGARVVLISTDNVFDGSLPHNTESTPVRPANAYGRAKLRAEQILLATAADAVVLRVSLVYGHEPAGAGKWLNFFASCAHQLLLGEAVHAPDDHWTTPVTVSDVARVTASVLFAPAPLPEVLHLGGPDRVTRAEWALTIADLLGAPRRLVVPVPKAATRYASRPENACLTSTSLPGLLGLIPVDGVAAGARKLVTAFTGRHAISRTPPGTGPVSTEPDRERG	MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGVLNTTPSIIQLTLSLYMVMLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAMLVATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALASLALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQLFGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV	80.20	gnl|BL_ORD_ID|2832|hsp_num:0	3786		
BGC0000804.1|Acarviostatin_27 # 38349 # 39743 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.718	BGC0000804.1|Acarviostatin_27 	38349	39743	-	Loose	500	81.6481	Escherichia coli ampH beta-lactamase	27.72	3004612	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGGCTCCGTTGCCTCAGCCGTCCGCCGATCCCACGGCCCAACCGATGGGCGGAACCGGGAAGTTGCTCCTGAGCCGGCTCGCTCGCGCCCAAGCCCTGGGGCGGGTCCCGTCCGTCGCGGGCTGTGCCCTGGTCGAAGGACGGACGGCCTGGACCGGCGTCCGCGGACGGGTGGGTGGCGGGTCGCCGACCTTGGACACGCAGTACCGGATCGGGTCGCTCACGAAGTCCTTCACAGCCGTTCTGGTGATGCGGTTGCGGGACCGGGGTGAGCTCAGGACGAACGACCCGCTGGACCGGTATCTGCCGGGCACCGGAATCGGAGACCGCACCCTTGAGCAACTCCTGAGTCACACCGCGGGGTTGACGACCATGACGCCAGGCTGTGACTGGCCGTACAGCGGACAGGGGCCGGCCGATCCGCTGCGGCGCGGGGCCGGGGTTCTCTGCGCGGCGGGGGAGCGCTTCCACTACTCGAATGTCGGGTACGCCCTTCTGGGCGCGGTGATCGAGAGGGTTCGGCAGGAGCCCTGGGCAGACGTGCTGGCCAGGGAGGTTCTCGCCCCACTGGGCATGAGAGGGACGGGCACGGACCCTGGTGCCGAGGCCGCTCCGGGATGGAGCGTGCACCCGTGGGCGCCGACGCTCGTGGCCGAAGAGGTCCAGGACGCCCGCGCCATGGCCGCCGCCGGGGCGCTGTGGTCCACGCCGGCGGACCTCGCCAGGTGGGCGGAGTTCCTCCTGGGCGACTGCGCCGAGGTGCTCCACCCGGACACGCTGGCCGAAATGGCCGAACCGACCCGGCTGTCCGCCCACGAGGACGAGCCCGGCGCCGGATTCGGACTGGGACTGCAGGCGGTACGGCACCAGGGACGCACTCTGATCGGACACCCCGGCGGCATACCGGGATTCCTGGCCACGATCTGGGTGGACCGAGAACGCCGGACGGGGGCAGTGATCGTCGGCAACGCCAGCACCGGGCTGAGCCCGAGCCGGGCCCTGGAACTGCTCGACATCGTGGGTGAGCAGACGCTGCCCCTGCCCGACGAGTGGGCGCCGCAAAACCTGCCGCCCCACCTTCTGGACCTCACGGGCTACTGGTACCAGGGCCCGCGTCCGCACGCCATCCAGATGGAGGCGGACGGCAGCGTGCTGCTGCAACCGGTGAGCACCCGCACCAAGCCTTCCCGCTTCCGCGCTCCGGCCAGCCGGTTCGGTACCACTCCGCAGGGCGGTCTGACCGGACTGGACGGCGCGTACGTGGGAGAGGAACTGCGGGTGCTCCGGGATCAGGACGGGCGGCCGGCGGCCCTCGAGCTCACCGGTGCCCGCTTCACCCGCGTTCCCGGTCCGGTTCCGTCGACACCGGCCCTGTCCCCGGAGGTGTCCGGCTGA	MAPLPQPSADPTAQPMGGTGKLLLSRLARAQALGRVPSVAGCALVEGRTAWTGVRGRVGGGSPTLDTQYRIGSLTKSFTAVLVMRLRDRGELRTNDPLDRYLPGTGIGDRTLEQLLSHTAGLTTMTPGCDWPYSGQGPADPLRRGAGVLCAAGERFHYSNVGYALLGAVIERVRQEPWADVLAREVLAPLGMRGTGTDPGAEAAPGWSVHPWAPTLVAEEVQDARAMAAAGALWSTPADLARWAEFLLGDCAEVLHPDTLAEMAEPTRLSAHEDEPGAGFGLGLQAVRHQGRTLIGHPGGIPGFLATIWVDRERRTGAVIVGNASTGLSPSRALELLDIVGEQTLPLPDEWAPQNLPPHLLDLTGYWYQGPRPHAIQMEADGSVLLQPVSTRTKPSRFRAPASRFGTTPQGGLTGLDGAYVGEELRVLRDQDGRPAALELTGARFTRVPGPVPSTPALSPEVSG	MKRSLLFSAVLCAASLTSVHAAQPITEPEFASDIVDRYADHIFYGSGATGMALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLNDPLSKYAPPGARVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQAAYSNLAFDLLADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIGSGGVYSTPGDMMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEGRPGIIQKTGGGGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS	120.52	gnl|BL_ORD_ID|2079|hsp_num:0	3307		
